personal information giancarlo logroscino …€¦ · personal information giancarlo logroscino ......

Curriculum vitae

PERSONAL INFORMATION Giancarlo Logroscino

WORK EXPERIENCE

January 2012–Present DirectorDepartment of Clinical Research in Neurology - University of Bari Aldo Moro at Card. G.Panico Hospital (Italy)

Clinical, Research, Teaching

January 2007–Present FULL ProfessorUniversity of Bari Aldo Moro (Italy)

Teaching, Clinical, Research

January 2002–December 2007 Associate ProfessorHarvard university (United States)

Research, Teaching

January 2004–December 2008 Adjunct - in Division of AgingHarvard School of Medicine (United States)

Research

January 1997–December 2002 Dirigente Medico I LivelloRegional Hospital Miulli (Italy)

Teaching, Clinical, Research

January 1992–December 1997 Researcher Sergievsky Center - Department of Neurology - Columbia University (United States)

Research, Clinica, Teaching

January 1986–December 1993 Neurology clinical AssistantRegional Hospital Miulli (Italy)

Clinical

January 1983–December 1986 Emergency Medical ServiceASL Bari (Italy)

Clinical

January 1981–December 1982 Medical Officer - IX Battaglione GRAPECAM FoggiaMinistero Difesa (Italy)

Clinical

EDUCATION AND TRAINING

2000–2000 Post graduate trainingDepartment of Epidemiology - John Hopkins University , Baltimora (United States)

Research

2/7/18 © European Union, 2002-2018 | http://europass.cedefop.europa.eu / 52

Curriculum vitae Giancarlo Logroscino

2002–2002 Post graduate trainingDuke University (United States)

Research

1999–1999 Post graduate training - Genetic Epidemiology and Molecular biology for Epidemiologic Studies Institute of Genetic Epidemiology (Netherlands)

Research

1997–1997 Doctorate of Philosophy in Epidemiology (PhD) Graduate School of Arts and Sciences Columbia University, New York, NY USA (United States)

Research

1996–1996 Post-Graduate Training. Linkage Analysis Department of Genetics and Development Columbia University (United States)

Research

1996–1996 Master of Philosophy (Mphyl) in EpidemiologyGraduate School of Arts and Sciences Columbia University, New York, NY USA (United States)

Research

1992–1992 Post-Graduate Training. Epidemiologic methods: introductory course Summer Graduate Session Department of Epidemiology University of Michigan, Ann Arbor, MI. (United States)

Research

1993–1993 Post-Graduate Training. Study Design. Clinical trialS. Summer Graduate Session Department of Epidemiology Johns Hopkins University, Baltimore, MD (United States)

Research

1994–1994 Master of Science in Epidemiology (MS)School of Public Health Columbia University, New York, NY USA (United States)

Research

1987–1987 Diploma in Clinical NeurochemistryInstitute of Neurology. Faculty of Medicine, University of Bari (Italy)

Research

1986–1986 Diploma in Neurochemistry and NeurophysiologyInstitute of Neurology. Faculty of Medicine, University of Bari (Italy)

Education

1984–1986 Research Fellow



Department of Neurology. School of Medicine, University of Bari (Italy)

Education

1984–1984 Specialization in NeurologyInstitute of Neurology. Faculty of Medicine, University of Bari (Italy)

Education

1980–1980 Degree in Medicine, University of BariInstitute of Neurology. Faculty of Medicine, University of Bari (Italy)

Education

ADDITIONAL INFORMATION

Expertise Giancarlo Logroscino, MD PhD is the director of the Neurodegenerative Diseases Unit of The University of Bari and Chair of the Department of Clinical Research in Neurology at Pia Fondazione Panico in Tricase (LE). He is an Associate Professor of Neurology at University of Bari. He has been trained in Neurology (University of Bari) and Epidemiology (PhD, Columbia University NYC). He has been associate professor of epidemiology and neurology at Harvard University (2002-2008).

His primary research interests are natural history of neurodegenerative diseses and environmental and genetic risk factors for neurodegenerative diseases related to aging. He has conducted studies onAmyotrophic Lateral Sclerosis, Parkinson’s disease, and Alzheimer’s disease, Fronto-temporal dementia, Dementia with Lewy body both in clinical settings and in population based settings.

He is leading projects and studies in the area of neurodegenerative diseases in Europe and outside Europe.

He established one of the first population-based registries of Amyotrophic Lateral Sclerosis in the world, (SLAP) based in Puglia, Southern Italy. He is a member of the committee of EURALS, the European project on descriptive and analytic factors of ALS. He is part of EUROMOTOR consortium, FP7 european project to study causes of ALS (chairman Leonard Van der Bergh, Utrecht), and of ENCALS, project to determine new pathways for treatment for ALS:. He is part of new consortium to determine new guidelines for Clinical trials in ALS (Chairman: Hiroshi Mitsumoto, New York).

He has recently establised a population based registry for Fronto-Lobar degeneration in Puglia (FTD_Apulia_registry)

In the last few years he added a new research focus: the aging brain and risk/protective factors for cognitive decline and longevity with data from prospective cohorts both in the US and Europe. He is the PI of the Great Age study, a population-based study on neurodegeneration aging, frailty in Castellana Grotte (BA), recently awarded by a special grant for aging research by Ministry of researchand Regione Puglia. He is working on methodological issues on longitudinal studies of neurodegenartive diseases. In this context is a member of MELODEM (methods in longitudinal studies of dementia).

He is part of the Global Burden of Disease (GBD) study and part of the neurodegenerative group of GBD.

He has been a member of the Chairs of Section Committtee (COE) of the American Academy of Neurology (AAN), chair of the neuroepidemiology section of the AAN (2013-2016). He is an active member of the Applied Research Committee (ARC) of the World Federation of Neurology (WFN) (2007-2017)

He is president of the Neuroepidemiological Italian Association (NEP) since 2014.

He is the convenor for the Neuroepidemiology Section of the last two meetings (Wien, Austria 2013; Santiago, Chile 2015) of the World Federation of Neurology (WFN)

He is menber of the scientific review panel of the American Brain Fondation since 2016.

He has published about 300 papers on highly impact factor journals including BMJ, JAMA, Lancet, Lancet Neurology, Annals of Neurology, Neurology and Brain and several chapters and books on neurodegenerative diseases and neuroepidemiology. He is the associated editor of the journal Neuroepidemiology, Karger, Basel.

Publications 1: Marin B, Fontana A, Arcuti S, Copetti M, Boumédiene F, Couratier P, Beghi E,



Preux PM, Logroscino G. Age-specific ALS incidence: a dose-response

meta-analysis. Eur J Epidemiol. 2018 Apr 23. doi: 10.1007/s10654-018-0392-x.

[Epub ahead of print] PubMed PMID: 29687175.

2: Visser AE, Rooney JPK, D'Ovidio F, Westeneng HJ, Vermeulen RCH, Beghi E, Chiò

A, Logroscino G, Hardiman O, Veldink JH, van den Berg LH; Euro-MOTOR consortium.

Multicentre, cross-cultural, population-based, case-control study of physical

activity as risk factor for amyotrophic lateral sclerosis. J Neurol Neurosurg

Psychiatry. 2018 Apr 23. pii: jnnp-2017-317724. doi: 10.1136/jnnp-2017-317724.


3: Logroscino G, Marin B, Piccininni M, Arcuti S, Chiò A, Hardiman O, Rooney J,

Zoccolella S, Couratier P, Preux PM, Beghi E; for EURALS. Referral bias in ALS

epidemiological studies. PLoS One. 2018 Apr 16;13(4):e0195821. doi:

10.1371/journal.pone.0195821. eCollection 2018. PubMed PMID: 29659621.

4: Bonham LW, Karch CM, Fan CC, Tan C, Geier EG, Wang Y, Wen N, Broce IJ, Li Y,

Barkovich MJ, Ferrari R, Hardy J, Momeni P, Höglinger G, Müller U, Hess CP,

Sugrue LP, Dillon WP, Schellenberg GD, Miller BL, Andreassen OA, Dale AM,

Barkovich AJ, Yokoyama JS, Desikan RS; International FTD-Genomics Consortium

(IFGC); International Parkinson’s Disease Genetics Consortium (IPDGC);

International Genomics of Alzheimer’s Project (IGAP). CXCR4 involvement in

neurodegenerative diseases. Transl Psychiatry. 2018 Apr 11;8(1):73. doi:

10.1038/s41398-017-0049-7. PubMed PMID: 29636460; PubMed Central PMCID:

PMC5893558.

5: Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna

BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt JJFA,

Geiger JT, Van der Spek RA, Pliner HA, Shankaracharya, Smith BN, Marangi G, Topp

SD, Abramzon Y, Gkazi AS, Eicher JD, Kenna A; ITALSGEN Consortium, Mora G, Calvo

A, Mazzini L, Riva N, Mandrioli J, Caponnetto C, Battistini S, Volanti P, La

Bella V, Conforti FL, Borghero G, Messina S, Simone IL, Trojsi F, Salvi F,

Logullo FO, D'Alfonso S, Corrado L, Capasso M, Ferrucci L; Genomic Translation

for ALS Care (GTAC) Consortium, Moreno CAM, Kamalakaran S, Goldstein DB; ALS

Sequencing Consortium, Gitler AD, Harris T, Myers RM; NYGC ALS Consortium,

Phatnani H, Musunuri RL, Evani US, Abhyankar A, Zody MC; Answer ALS Foundation,

Kaye J, Finkbeiner S, Wyman SK, LeNail A, Lima L, Fraenkel E, Svendsen CN,

Thompson LM, Van Eyk JE, Berry JD, Miller TM, Kolb SJ, Cudkowicz M, Baxi E;

Clinical Research in ALS and Related Disorders for Therapeutic Development

(CReATe) Consortium, Benatar M, Taylor JP, Rampersaud E, Wu G, Wuu J; SLAGEN

Consortium, Lauria G, Verde F, Fogh I, Tiloca C, Comi GP, Sorarù G, Cereda C;

French ALS Consortium, Corcia P, Laaksovirta H, Myllykangas L, Jansson L, Valori

M, Ealing J, Hamdalla H, Rollinson S, Pickering-Brown S, Orrell RW, Sidle KC,

Malaspina A, Hardy J, Singleton AB, Johnson JO, Arepalli S, Sapp PC,

McKenna-Yasek D, Polak M, Asress S, Al-Sarraj S, King A, Troakes C, Vance C, de

Belleroche J, Baas F, Ten Asbroek ALMA, Muñoz-Blanco JL, Hernandez DG, Ding J,

Gibbs JR, Scholz SW, Floeter MK, Campbell RH, Landi F, Bowser R, Pulst SM, Ravits

JM, MacGowan DJL, Kirby J, Pioro EP, Pamphlett R, Broach J, Gerhard G, Dunckley

TL, Brady CB, Kowall NW, Troncoso JC, Le Ber I, Mouzat K, Lumbroso S,

Heiman-Patterson TD, Kamel F, Van Den Bosch L, Baloh RH, Strom TM, Meitinger T,

Shatunov A, Van Eijk KR, de Carvalho M, Kooyman M, Middelkoop B, Moisse M,



McLaughlin RL, Van Es MA, Weber M, Boylan KB, Van Blitterswijk M, Rademakers R,

Morrison KE, Basak AN, Mora JS, Drory VE, Shaw PJ, Turner MR, Talbot K, Hardiman

O, Williams KL, Fifita JA, Nicholson GA, Blair IP, Rouleau GA, Esteban-Pérez J,

García-Redondo A, Al-Chalabi A; Project MinE ALS Sequencing Consortium, Rogaeva

E, Zinman L, Ostrow LW, Maragakis NJ, Rothstein JD, Simmons Z, Cooper-Knock J,

Brice A, Goutman SA, Feldman EL, Gibson SB, Taroni F, Ratti A, Gellera C, Van

Damme P, Robberecht W, Fratta P, Sabatelli M, Lunetta C, Ludolph AC, Andersen PM,

Weishaupt JH, Camu W, Trojanowski JQ, Van Deerlin VM, Brown RH Jr., van den Berg

LH, Veldink JH, Harms MB, Glass JD, Stone DJ, Tienari P, Silani V, Chiò A, Shaw

CE, Traynor BJ, Landers JE. Genome-wide Analyses Identify KIF5A as a Novel ALS

Gene. Neuron. 2018 Mar 21;97(6):1268-1283.e6. doi: 10.1016/j.neuron.2018.02.027.

PubMed PMID: 29566793; PubMed Central PMCID: PMC5867896.

6: Panza F, Lozupone M, Solfrizzi V, Sardone R, Dibello V, Di Lena L, D'Urso F,

Stallone R, Petruzzi M, Giannelli G, Quaranta N, Bellomo A, Greco A, Daniele A,

Seripa D, Logroscino G. Different Cognitive Frailty Models and Health- and

Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention. J

Alzheimers Dis. 2018;62(3):993-1012. doi: 10.3233/JAD-170963. PubMed PMID:

29562543; PubMed Central PMCID: PMC5870024.

7: Tortelli R, Arcuti S, Copetti M, Barone R, Zecca C, Capozzo R, Barulli MR,

Simone IL, Logroscino G. Pseudobulbar affect as a negative prognostic indicator

in amyotrophic lateral sclerosis. Acta Neurol Scand. 2018 Mar 11. doi:

10.1111/ane.12918. [Epub ahead of print] PubMed PMID: 29527672.

8: Mandrioli J, Ferri L, Fasano A, Zucchi E, Fini N, Moglia C, Lunetta C, Marinou

K, Ticozzi N, Drago Ferrante G, Scialo C, Sorarù G, Trojsi F, Conte A, Falzone

YM, Tortelli R, Russo M, Sansone VA, Mora G, Silani V, Volanti P, Caponnetto C,

Querin G, Monsurrò MR, Sabatelli M, Chiò A, Riva N, Logroscino G, Messina S,

Calvo A. Cardiovascular diseases may play a negative role in the prognosis of

amyotrophic lateral sclerosis. Eur J Neurol. 2018 Mar 7. doi: 10.1111/ene.13620.


9: Devito F, Zito A, Dragonieri S, Carratù P, Quaranta VN, Vitale F, Quaranta N,

Panza F, Logroscino G, Cameli M, Resta O, Ciccone MM. Evaluation of endothelial

function and cardiovascular risk in non-obese patients with slight degree of

obstructive sleep apnea syndrome. Monaldi Arch Chest Dis. 2017 Dec 5;87(3):822.

doi: 10.4081/monaldi.2017.822. PubMed PMID: 29424194.

10: Broce I, Karch CM, Wen N, Fan CC, Wang Y, Tan CH, Kouri N, Ross OA, Höglinger

GU, Muller U, Hardy J; International FTD-Genomics Consortium, Momeni P, Hess CP,

Dillon WP, Miller ZA, Bonham LW, Rabinovici GD, Rosen HJ, Schellenberg GD, Franke

A, Karlsen TH, Veldink JH, Ferrari R, Yokoyama JS, Miller BL, Andreassen OA, Dale

AM, Desikan RS, Sugrue LP. Immune-related genetic enrichment in frontotemporal

dementia: An analysis of genome-wide association studies. PLoS Med. 2018 Jan

9;15(1):e1002487. doi: 10.1371/journal.pmed.1002487. eCollection 2018 Jan.

Erratum in: PLoS Med. 2018 Jan 29;15(1):e1002504. PubMed PMID: 29315334; PubMed

Central PMCID: PMC5760014.

11: Panza F, Quaranta N, Logroscino G. Sensory Changes and the Hearing

Loss-Cognition Link: The Cognitive Ear. JAMA Otolaryngol Head Neck Surg. 2018 Feb

1;144(2):127-128. doi: 10.1001/jamaoto.2017.2514. PubMed PMID: 29222539.

12: van Zwieten A, Wong G, Ruospo M, Palmer SC, Barulli MR, Iurillo A, Saglimbene



V, Natale P, Gargano L, Murgo M, Loy CT, Tortelli R, Craig JC, Johnson DW,

Tonelli M, Hegbrant J, Wollheim C, Logroscino G, Strippoli GFM; COGNITIVE-HD

study investigators. Prevalence and patterns of cognitive impairment in adult

hemodialysis patients: the COGNITIVE-HD study. Nephrol Dial Transplant. 2017 Nov

22. doi: 10.1093/ndt/gfx314. [Epub ahead of print] PubMed PMID: 29186522.

13: Carabellese F, Felthous AR, La Tegola D, Piazzolla G, Distaso S, Logroscino

G, Leo A, Ventriglio A, Catanesi R. Qualitative analysis of the capacity to

consent to treatment in patients with a chronic neurodegenerative disease:

Alzheimer's disease / Analisi qualitativa sulla capacità a prestare consenso al

trattamento in pazienti con malattie cronico degenerative neuropsicoorganiche:

Demenza di Alzheimer. Int J Soc Psychiatry. 2018 Feb;64(1):26-36. doi:

10.1177/0020764017739642. Epub 2017 Nov 28. PubMed PMID: 29183264.

14: Pupillo E, Poloni M, Bianchi E, Giussani G, Logroscino G, Zoccolella S, Chiò

A, Calvo A, Corbo M, Lunetta C, Marin B, Mitchell D, Hardiman O, Rooney J, Stevic

Z, Bandettini di Poggio M, Filosto M, Cotelli MS, Perini M, Riva N, Tremolizzo L,

Vitelli E, Damiani D, Beghi E; EURALS Consortium†. Trauma and amyotrophic lateral

sclerosis: a european population-based case-control study from the EURALS

consortium. Amyotroph Lateral Scler Frontotemporal Degener. 2018

Feb;19(1-2):118-125. doi: 10.1080/21678421.2017.1386687. Epub 2017 Oct 24. PubMed

PMID: 29063790.

15: Skrobot OA, Black SE, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN,

O'Brien J, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I; VICCCS

group, Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG. Progress toward standardized

diagnosis of vascular cognitive impairment: Guidelines from the Vascular

Impairment of Cognition Classification Consensus Study. Alzheimers Dement. 2018

Mar;14(3):280-292. doi: 10.1016/j.jalz.2017.09.007. Epub 2017 Oct 19. PubMed

PMID: 29055812.

16: Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw

PJ, Simmons Z, van den Berg LH. Amyotrophic lateral sclerosis. Nat Rev Dis

Primers. 2017 Oct 20;3:17085. doi: 10.1038/nrdp.2017.85. PubMed PMID: 29052611.

17: Panza F, Seripa D, Lozupone M, Solfrizzi V, Imbimbo BP, Barulli MR, Tortelli

R, Capozzo R, Bisceglia P, Dimitri A, Stallone R, Dibello V, Quaranta N, Daniele

A, Bellomo A, Greco A, Logroscino G. The potential of solanezumab and

gantenerumab to prevent Alzheimer's disease in people with inherited mutations

that cause its early onset. Expert Opin Biol Ther. 2018 Jan;18(1):25-35. doi:

10.1080/14712598.2018.1389885. Epub 2017 Oct 16. Review. PubMed PMID: 29037101.

18: Rizzo G, Arcuti S, Copetti M, Alessandria M, Savica R, Fontana A, Liguori R,

Logroscino G. Accuracy of clinical diagnosis of dementia with Lewy bodies: a

systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2018

Apr;89(4):358-366. doi: 10.1136/jnnp-2017-316844. Epub 2017 Oct 13. PubMed PMID:

29030419.

19: Seripa D, Lozupone M, Stella E, Paroni G, Bisceglia P, La Montagna M,

D'onofrio G, Gravina C, Urbano M, Priore MG, Lamanna A, Daniele A, Bellomo A,

Logroscino G, Greco A, Panza F. Psychotropic drugs and CYP2D6 in late-life

psychiatric and neurological disorders. What do we know? Expert Opin Drug Saf.

2017 Dec;16(12):1373-1385. doi: 10.1080/14740338.2017.1389891. Epub 2017 Oct 12.

Review. PubMed PMID: 29025271.



20: Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw

PJ, Simmons Z, van den Berg LH. Amyotrophic lateral sclerosis. Nat Rev Dis

Primers. 2017 Oct 5;3:17071. doi: 10.1038/nrdp.2017.71. Review. Erratum in: Nat

Rev Dis Primers. 2017 Oct 20;3:17085. PubMed PMID: 28980624.

21: GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and

national burden of neurological disorders during 1990-2015: a systematic analysis

for the Global Burden of Disease Study 2015. Lancet Neurol. 2017

Nov;16(11):877-897. doi: 10.1016/S1474-4422(17)30299-5. Epub 2017 Sep 17. PubMed

PMID: 28931491; PubMed Central PMCID: PMC5641502.

22: GBD 2016 Risk Factors Collaborators. Global, regional, and national

comparative risk assessment of 84 behavioural, environmental and occupational,

and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for

the Global Burden of Disease Study 2016. Lancet. 2017 Sep

16;390(10100):1345-1422. doi: 10.1016/S0140-6736(17)32366-8. PubMed PMID:


23: GBD 2016 DALYs and HALE Collaborators. Global, regional, and national

disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy

life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic

analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep

16;390(10100):1260-1344. doi: 10.1016/S0140-6736(17)32130-X. PubMed PMID:


24: GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global,

regional, and national incidence, prevalence, and years lived with disability for

328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for

the Global Burden of Disease Study 2016. Lancet. 2017 Sep

16;390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2. PubMed PMID:


25: GBD 2016 Causes of Death Collaborators. Global, regional, and national

age-sex specific mortality for 264 causes of death, 1980-2016: a systematic

analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep

16;390(10100):1151-1210. doi: 10.1016/S0140-6736(17)32152-9. PubMed PMID:


26: GBD 2016 Mortality Collaborators. Global, regional, and national under-5

mortality, adult mortality, age-specific mortality, and life expectancy,

1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Lancet. 2017 Sep 16;390(10100):1084-1150. doi: 10.1016/S0140-6736(17)31833-0.


27: Trojsi F, Siciliano M, Femiano C, Santangelo G, Lunetta C, Calvo A, Moglia C,

Marinou K, Ticozzi N, Drago Ferrante G, Scialò C, Sorarù G, Conte A, Falzone YM,

Tortelli R, Russo M, Sansone VA, Chiò A, Mora G, Poletti B, Volanti P, Caponnetto

C, Querin G, Sabatelli M, Riva N, Logroscino G, Messina S, Fasano A, Monsurrò MR,

Tedeschi G, Mandrioli J. Comorbidity of dementia with amyotrophic lateral

sclerosis (ALS): insights from a large multicenter Italian cohort. J Neurol. 2017

Nov;264(11):2224-2231. doi: 10.1007/s00415-017-8619-4. Epub 2017 Sep 15. PubMed

PMID: 28914354.

28: Dandaba M, Couratier P, Labrunie A, Nicol M, Hamidou B, Raymondeau M,

Logroscino G, Preux PM, Marin B; FRALIM Consortium. Characteristics and Prognosis



of Oldest Old Subjects with Amyotrophic Lateral Sclerosis. Neuroepidemiology.

2017;49(1-2):64-73. doi: 10.1159/000479969. Epub 2017 Sep 5. PubMed PMID:

28873374.

29: Lozupone M, Seripa D, Stella E, La Montagna M, Solfrizzi V, Quaranta N,

Veneziani F, Cester A, Sardone R, Bonfiglio C, Giannelli G, Bisceglia P,

Bringiotti R, Daniele A, Greco A, Bellomo A, Logroscino G, Panza F. Innovative

biomarkers in psychiatric disorders: a major clinical challenge in psychiatry.

Expert Rev Proteomics. 2017 Sep;14(9):809-824. doi:

10.1080/14789450.2017.1375857. Epub 2017 Sep 11. PubMed PMID: 28870126.

30: Panza F, Lozupone M, Solfrizzi V, Stallone R, Bellomo A, Greco A, Daniele A,

Seripa D, Logroscino G. Cognitive frailty: a potential target for secondary

prevention of dementia. Expert Opin Drug Metab Toxicol. 2017

Oct;13(10):1023-1027. doi: 10.1080/17425255.2017.1372424. Epub 2017 Sep 5. PubMed

PMID: 28849681.

31: Di Pietro L, Baranzini M, Berardinelli MG, Lattanzi W, Monforte M, Tasca G,

Conte A, Logroscino G, Michetti F, Ricci E, Sabatelli M, Bernardini C. Potential

therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during

disease progression in the skeletal muscle of patients. Sci Rep. 2017 Aug

25;7(1):9538. doi: 10.1038/s41598-017-10161-z. PubMed PMID: 28842714; PubMed


32: Rooney JPK, Visser AE, D'Ovidio F, Vermeulen R, Beghi E, Chio A, Veldink JH,

Logroscino G, van den Berg LH, Hardiman O; Euro-MOTOR Consortium. A case-control

study of hormonal exposures as etiologic factors for ALS in women: Euro-MOTOR.

Neurology. 2017 Sep 19;89(12):1283-1290. doi: 10.1212/WNL.0000000000004390. Epub

2017 Aug 23. PubMed PMID: 28835399.

33: Sprio S, Dapporto M, Montesi M, Panseri S, Lattanzi W, Pola E, Logroscino G,

Tampieri A. Novel Osteointegrative Sr-Substituted Apatitic Cements Enriched with

Alginate. Materials (Basel). 2016 Sep 8;9(9). pii: E763. doi: 10.3390/ma9090763.


34: Solfrizzi V, Custodero C, Lozupone M, Imbimbo BP, Valiani V, Agosti P,

Schilardi A, D'Introno A, La Montagna M, Calvani M, Guerra V, Sardone R,

Abbrescia DI, Bellomo A, Greco A, Daniele A, Seripa D, Logroscino G, Sabbá C,

Panza F. Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients

with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review.

J Alzheimers Dis. 2017;59(3):815-849. doi: 10.3233/JAD-170248. Review. PubMed

PMID: 28697569.

35: Solfrizzi V, Scafato E, Lozupone M, Seripa D, Giannini M, Sardone R,

Bonfiglio C, Abbrescia DI, Galluzzo L, Gandin C, Baldereschi M, Di Carlo A,

Inzitari D, Daniele A, Sabbà C, Logroscino G, Panza F; Italian Longitudinal Study

on Aging Working Group. Additive Role of a Potentially Reversible Cognitive

Frailty Model and Inflammatory State on the Risk of Disability: The Italian

Longitudinal Study on Aging. Am J Geriatr Psychiatry. 2017 Nov;25(11):1236-1248.

doi: 10.1016/j.jagp.2017.05.018. Epub 2017 Jul 6. PubMed PMID: 28689645.

36: Panza F, Solfrizzi V, Lozupone M, Barulli MR, D'Urso F, Stallone R, Dibello

V, Noia A, Di Dio C, Daniele A, Bellomo A, Seripa D, Greco A, Logroscino G. An

Old Challenge with New Promises: A Systematic Review on Comprehensive Geriatric

Assessment in Long-Term Care Facilities. Rejuvenation Res. 2018 Feb;21(1):3-14.



doi: 10.1089/rej.2017.1964. Epub 2017 Jul 28. PubMed PMID: 28635539.

37: Seripa D, Panza F, Paroni G, D'Onofrio G, Bisceglia P, Gravina C, Urbano M,

Lozupone M, Solfrizzi V, Bizzarro A, Boccardi V, Piccininni C, Daniele A,

Logroscino G, Mecocci P, Masullo C, Greco A. Role of CLU, PICALM, and TNK1

Genotypes in Aging With and Without Alzheimer's Disease. Mol Neurobiol. 2018

May;55(5):4333-4344. doi: 10.1007/s12035-017-0547-x. Epub 2017 Jun 19. PubMed

PMID: 28631188.

38: D'Ovidio F, Rooney JPK, Visser AE, Vermeulen RCH, Veldink JH, Van Den Berg

LH, Hardiman O, Logroscino G, Chiò A, Beghi E; Euro-MOTOR Group. Critical issues

in ALS case-control studies: the case of the Euro-MOTOR study. Amyotroph Lateral

Scler Frontotemporal Degener. 2017 Aug;18(5-6):411-418. doi:

10.1080/21678421.2017.1285939. Epub 2017 Feb 10. PubMed PMID: 28594593.

39: Tortelli R, Lozupone M, Guerra V, Barulli MR, Imbimbo BP, Capozzo R, Grasso

A, Tursi M, Di Dio C, Sardone R, Giannelli G, Seripa D, Misciagna G, Panza F,

Logroscino G. Midlife Metabolic Profile and the Risk of Late-Life Cognitive

Decline. J Alzheimers Dis. 2017;59(1):121-130. doi: 10.3233/JAD-170153. PubMed

PMID: 28582862.

40: GBD 2015 Healthcare Access and Quality Collaborators. Electronic address:

[email protected]; GBD 2015 Healthcare Access and Quality Collaborators. Healthcare

Access and Quality Index based on mortality from causes amenable to personal

health care in 195 countries and territories, 1990-2015: a novel analysis from

the Global Burden of Disease Study 2015. Lancet. 2017 Jul 15;390(10091):231-266.

doi: 10.1016/S0140-6736(17)30818-8. Epub 2017 May 18. PubMed PMID: 28528753;

PubMed Central PMCID: PMC5528124.

41: Rooney JPK, Brayne C, Tobin K, Logroscino G, Glymour MM, Hardiman O.

Benefits, pitfalls, and future design of population-based registers in

neurodegenerative disease. Neurology. 2017 Jun 13;88(24):2321-2329. doi:

10.1212/WNL.0000000000004038. Epub 2017 May 17. Review. PubMed PMID: 28515268.

42: Luna J, Logroscino G, Couratier P, Marin B. Current issues in ALS

epidemiology: Variation of ALS occurrence between populations and physical

activity as a risk factor. Rev Neurol (Paris). 2017 May;173(5):244-253. doi:

10.1016/j.neurol.2017.03.035. Epub 2017 May 3. Review. PubMed PMID: 28477849.

43: McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O'Brien M, Kahn RS,

Ophoff RA, Goris A, Bradley DG, Al-Chalabi A, van den Berg LH, Luykx JJ, Hardiman

O, Veldink JH; Project MinE GWAS Consortium; Schizophrenia Working Group of the

Psychiatric Genomics Consortium. Genetic correlation between amyotrophic lateral

sclerosis and schizophrenia. Nat Commun. 2017 Mar 21;8:14774. doi:

10.1038/ncomms14774. PubMed PMID: 28322246; PubMed Central PMCID: PMC5364411.

44: Hardiman O, Al-Chalabi A, Brayne C, Beghi E, van den Berg LH, Chio A, Martin

S, Logroscino G, Rooney J. The changing picture of amyotrophic lateral sclerosis:

lessons from European registers. J Neurol Neurosurg Psychiatry. 2017

Jul;88(7):557-563. doi: 10.1136/jnnp-2016-314495. Epub 2017 Mar 11. Review.

PubMed PMID: 28285264.

45: Capozzo R, Sassi C, Hammer MB, Arcuti S, Zecca C, Barulli MR, Tortelli R,

Gibbs JR, Crews C, Seripa D, Carnicella F, Dell'Aquila C, Rossi M, Tamma F,

Valluzzi F, Brancasi B, Panza F, Singleton AB, Logroscino G. Clinical and genetic

analyses of familial and sporadic frontotemporal dementia patients in Southern



Italy. Alzheimers Dement. 2017 Aug;13(8):858-869. doi:

10.1016/j.jalz.2017.01.011. Epub 2017 Mar 3. PubMed PMID: 28264768.

46: Triggiani AI, Bevilacqua V, Brunetti A, Lizio R, Tattoli G, Cassano F,

Soricelli A, Ferri R, Nobili F, Gesualdo L, Barulli MR, Tortelli R, Cardinali V,

Giannini A, Spagnolo P, Armenise S, Stocchi F, Buenza G, Scianatico G, Logroscino

G, Lacidogna G, Orzi F, Buttinelli C, Giubilei F, Del Percio C, Frisoni GB,

Babiloni C. Classification of Healthy Subjects and Alzheimer's Disease Patients

with Dementia from Cortical Sources of Resting State EEG Rhythms: A Study Using

Artificial Neural Networks. Front Neurosci. 2017 Jan 26;10:604. doi:

10.3389/fnins.2016.00604. eCollection 2016. PubMed PMID: 28184183; PubMed Central

PMCID: PMC5266711.

47: Pilotto A, Cella A, Pilotto A, Daragjati J, Veronese N, Musacchio C, Mello

AM, Logroscino G, Padovani A, Prete C, Panza F. Three Decades of Comprehensive

Geriatric Assessment: Evidence Coming From Different Healthcare Settings and

Specific Clinical Conditions. J Am Med Dir Assoc. 2017 Feb

1;18(2):192.e1-192.e11. doi: 10.1016/j.jamda.2016.11.004. Epub 2016 Dec 31.


48: Solfrizzi V, Scafato E, Seripa D, Lozupone M, Imbimbo BP, D'Amato A, Tortelli

R, Schilardi A, Galluzzo L, Gandin C, Baldereschi M, Di Carlo A, Inzitari D,

Daniele A, Sabbà C, Logroscino G, Panza F; Italian Longitudinal Study on Aging

Working Group. Reversible Cognitive Frailty, Dementia, and All-Cause Mortality.

The Italian Longitudinal Study on Aging. J Am Med Dir Assoc. 2017

Jan;18(1):89.e1-89.e8. doi: 10.1016/j.jamda.2016.10.012. PubMed PMID: 28012505.

49: Levira F, Thurman DJ, Sander JW, Hauser WA, Hesdorffer DC, Masanja H,

Odermatt P, Logroscino G, Newton CR; Epidemiology Commission of the International

League Against Epilepsy. Premature mortality of epilepsy in low- and

middle-income countries: A systematic review from the Mortality Task Force of the

International League Against Epilepsy. Epilepsia. 2017 Jan;58(1):6-16. doi:

10.1111/epi.13603. Epub 2016 Dec 18. Review. PubMed PMID: 27988968.

50: Skrobot OA, O'Brien J, Black S, Chen C, DeCarli C, Erkinjuntti T, Ford GA,

Kalaria RN, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I; VICCCS

group, Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG. The Vascular Impairment of

Cognition Classification Consensus Study. Alzheimers Dement. 2017

Jun;13(6):624-633. doi: 10.1016/j.jalz.2016.10.007. Epub 2016 Dec 10. PubMed

PMID: 27960092.

51: Panza F, Logroscino G. Anti-tau vaccine in Alzheimer's disease: a tentative

step. Lancet Neurol. 2017 Feb;16(2):99-100. doi: 10.1016/S1474-4422(16)30340-4.

Epub 2016 Dec 10. PubMed PMID: 27955996.

52: Ferrari R, Wang Y, Vandrovcova J, Guelfi S, Witeolar A, Karch CM, Schork AJ,

Fan CC, Brewer JB; International FTD-Genomics Consortium (IFGC),; International

Parkinson's Disease Genomics Consortium (IPDGC),; International Genomics of

Alzheimer's Project (IGAP),, Momeni P, Schellenberg GD, Dillon WP, Sugrue LP,

Hess CP, Yokoyama JS, Bonham LW, Rabinovici GD, Miller BL, Andreassen OA, Dale

AM, Hardy J, Desikan RS. Genetic architecture of sporadic frontotemporal dementia

and overlap with Alzheimer's and Parkinson's diseases. J Neurol Neurosurg

Psychiatry. 2017 Feb;88(2):152-164. doi: 10.1136/jnnp-2016-314411. Epub 2016 Nov

29. PubMed PMID: 27899424; PubMed Central PMCID: PMC5237405.



53: Thurman DJ, Logroscino G, Beghi E, Hauser WA, Hesdorffer DC, Newton CR,

Scorza FA, Sander JW, Tomson T; Epidemiology Commission of the International

League Against Epilepsy. The burden of premature mortality of epilepsy in

high-income countries: A systematic review from the Mortality Task Force of the

International League Against Epilepsy. Epilepsia. 2017 Jan;58(1):17-26. doi:

10.1111/epi.13604. Epub 2016 Nov 26. Review. PubMed PMID: 27888514.

54: Leo A, La Tegola D, Logroscino G, Carabellese F. Approach to the patient

hospitalized during the Muslim Ramadan: bioethical and clinical considerations.

Riv Psichiatr. 2016 Sep-Oct;51(5):172-176. doi: 10.1708/2476.25884. PubMed PMID:

27869903.

55: Pisa FE, Logroscino G, Giacomelli Battiston P, Barbone F. Hospitalizations

due to respiratory failure in patients with Amyotrophic Lateral Sclerosis and

their impact on survival: a population-based cohort study. BMC Pulm Med. 2016 Nov

3;16(1):136. PubMed PMID: 27809826; PubMed Central PMCID: PMC5094098.

56: Papazacharias A, Lozupone M, Barulli MR, Capozzo R, Imbimbo BP, Veneziani F,

De Blasi R, Nardini M, Seripa D, Panza F, Logroscino G. Bipolar Disorder and

Frontotemporal Dementia: An Intriguing Association. J Alzheimers Dis.

2017;55(3):973-979. PubMed PMID: 27802240.

57: Fazio L, Logroscino G, Taurisano P, Amico G, Quarto T, Antonucci LA, Barulli

MR, Mancini M, Gelao B, Ferranti L, Popolizio T, Bertolino A, Blasi G. Prefrontal

Activity and Connectivity with the Basal Ganglia during Performance of Complex

Cognitive Tasks Is Associated with Apathy in Healthy Subjects. PLoS One. 2016 Oct

31;11(10):e0165301. doi: 10.1371/journal.pone.0165301. eCollection 2016. PubMed


58: Calvo A, Moglia C, Lunetta C, Marinou K, Ticozzi N, Ferrante GD, Scialo C,

Sorarù G, Trojsi F, Conte A, Falzone YM, Tortelli R, Russo M, Chiò A, Sansone VA,

Mora G, Silani V, Volanti P, Caponnetto C, Querin G, Monsurrò MR, Sabatelli M,

Riva N, Logroscino G, Messina S, Fini N, Mandrioli J. Factors predicting survival

in ALS: a multicenter Italian study. J Neurol. 2017 Jan;264(1):54-63. doi:

10.1007/s00415-016-8313-y. Epub 2016 Oct 24. PubMed PMID: 27778156.

59: Rizzo G, Zanigni S, De Blasi R, Grasso D, Martino D, Savica R, Logroscino G.

Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An

Update. Parkinsons Dis. 2016;2016:2983638. Epub 2016 Sep 28. Review. PubMed PMID:


60: GBD 2015 Child Mortality Collaborators. Global, regional, national, and

selected subnational levels of stillbirths, neonatal, infant, and under-5

mortality, 1980-2015: a systematic analysis for the Global Burden of Disease

Study 2015. Lancet. 2016 Oct 8;388(10053):1725-1774. doi:

10.1016/S0140-6736(16)31575-6. PubMed PMID: 27733285; PubMed Central PMCID:

PMC5224696.

61: GBD 2015 Risk Factors Collaborators. Global, regional, and national

comparative risk assessment of 79 behavioural, environmental and occupational,

and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for

the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1659-1724.

doi: 10.1016/S0140-6736(16)31679-8. PubMed PMID: 27733284; PubMed Central PMCID:

PMC5388856.

62: GBD 2015 DALYs and HALE Collaborators. Global, regional, and national



disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy

life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of

Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1603-1658. doi:

10.1016/S0140-6736(16)31460-X. PubMed PMID: 27733283; PubMed Central PMCID:

PMC5388857.

63: GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global,

regional, and national incidence, prevalence, and years lived with disability for

310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden

of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1545-1602. doi:


PMC5055577.

64: GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and

national life expectancy, all-cause mortality, and cause-specific mortality for

249 causes of death, 1980-2015: a systematic analysis for the Global Burden of



PMC5388903.

65: Lozupone M, Panza F, Stella E, La Montagna M, Bisceglia P, Miscio G, Galizia

I, Daniele A, di Mauro L, Bellomo A, Logroscino G, Greco A, Seripa D.

Pharmacogenetics of neurological and psychiatric diseases at older age: has the

time come? Expert Opin Drug Metab Toxicol. 2017 Mar;13(3):259-277. doi:

10.1080/17425255.2017.1246533. Epub 2016 Oct 20. Review. PubMed PMID: 27718745.

66: Panza F, Seripa D, Solfrizzi V, Imbimbo BP, Lozupone M, Leo A, Sardone R,

Gagliardi G, Lofano L, Creanza BC, Bisceglia P, Daniele A, Bellomo A, Greco A,

Logroscino G. Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's

disease patients. Expert Opin Emerg Drugs. 2016 Dec;21(4):377-391. Epub 2016 Oct

6. Review. PubMed PMID: 27678025.

67: GBD 2015 SDG Collaborators. Measuring the health-related Sustainable

Development Goals in 188 countries: a baseline analysis from the Global Burden of


10.1016/S0140-6736(16)31467-2. Epub 2016 Sep 21. PubMed PMID: 27665228; PubMed


68: Logroscino G. Classifying change and heterogeneity in amyotrophic lateral

sclerosis. Lancet Neurol. 2016 Oct;15(11):1111-2. doi:

10.1016/S1474-4422(16)30206-X. PubMed PMID: 27647633.

69: Savica R, Boeve BF, Logroscino G. Epidemiology of alpha-synucleinopathies:

from Parkinson disease to dementia with Lewy bodies. Handb Clin Neurol.

2016;138:153-8. doi: 10.1016/B978-0-12-802973-2.00009-4. Review. PubMed PMID:

27637957.

70: Panza F, Solfrizzi V, Seripa D, Imbimbo BP, Lozupone M, Santamato A, Tortelli

R, Galizia I, Prete C, Daniele A, Pilotto A, Greco A, Logroscino G. Tau-based

therapeutics for Alzheimer's disease: active and passive immunotherapy.

Immunotherapy. 2016 Sep;8(9):1119-34. doi: 10.2217/imt-2016-0019. PubMed PMID:

27485083.

71: Santamato A, Panza F, Notarnicola A, Cassatella G, Fortunato F, de Sanctis

JL, Valeno G, Kehoe PG, Seripa D, Logroscino G, Fiore P, Ranieri M. Is

Extracorporeal Shockwave Therapy Combined With Isokinetic Exercise More Effective



Than Extracorporeal Shockwave Therapy Alone for Subacromial Impingement Syndrome?

A Randomized Clinical Trial. J Orthop Sports Phys Ther. 2016 Sep;46(9):714-25.

doi: 10.2519/jospt.2016.4629. Epub 2016 Jul 31. PubMed PMID: 27477254.

72: GBD 2015 HIV Collaborators. Estimates of global, regional, and national

incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of

Disease Study 2015. Lancet HIV. 2016 Aug;3(8):e361-e387. doi:

10.1016/S2352-3018(16)30087-X. Epub 2016 Jul 19. Erratum in: Lancet HIV. 2016

Sep;3(9):e408. PubMed PMID: 27470028; PubMed Central PMCID: PMC5056319.

73: Tortelli R, Seripa D, Panza F, Solfrizzi V, Logroscino G. Pharmacogenetics in

Neurodegenerative Diseases: Implications for Clinical Trials. Front Neurol

Neurosci. 2016;39:124-35. doi: 10.1159/000445453. Epub 2016 Jul 26. Review.


74: Logroscino G, Capozzo R, Tortelli R, Marin B. Current Issues in Randomized

Clinical Trials of Neurodegenerative Disorders at Enrolment and Reporting:

Diagnosis, Recruitment, Representativeness of Patients, Ethnicity, and Quality of

Reporting. Front Neurol Neurosci. 2016;39:24-36. doi: 10.1159/000445410. Epub

2016 Jul 26. Review. PubMed PMID: 27463823.

75: Beghi E, Logroscino G. General Overview, Conclusions, and Future Directions.

Front Neurol Neurosci. 2016;39:154-62. doi: 10.1159/000445456. Epub 2016 Jul 26.


76: van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL,

van der Spek RA, Võsa U, de Jong S, Robinson MR, Yang J, Fogh I, van Doormaal PT,

Tazelaar GH, Koppers M, Blokhuis AM, Sproviero W, Jones AR, Kenna KP, van Eijk

KR, Harschnitz O, Schellevis RD, Brands WJ, Medic J, Menelaou A, Vajda A, Ticozzi

N, Lin K, Rogelj B, Vrabec K, Ravnik-Glavač M, Koritnik B, Zidar J, Leonardis L,

Grošelj LD, Millecamps S, Salachas F, Meininger V, de Carvalho M, Pinto S, Mora

JS, Rojas-García R, Polak M, Chandran S, Colville S, Swingler R, Morrison KE,

Shaw PJ, Hardy J, Orrell RW, Pittman A, Sidle K, Fratta P, Malaspina A, Topp S,

Petri S, Abdulla S, Drepper C, Sendtner M, Meyer T, Ophoff RA, Staats KA,

Wiedau-Pazos M, Lomen-Hoerth C, Van Deerlin VM, Trojanowski JQ, Elman L,

McCluskey L, Basak AN, Tunca C, Hamzeiy H, Parman Y, Meitinger T, Lichtner P,

Radivojkov-Blagojevic M, Andres CR, Maurel C, Bensimon G, Landwehrmeyer B, Brice

A, Payan CA, Saker-Delye S, Dürr A, Wood NW, Tittmann L, Lieb W, Franke A,

Rietschel M, Cichon S, Nöthen MM, Amouyel P, Tzourio C, Dartigues JF,

Uitterlinden AG, Rivadeneira F, Estrada K, Hofman A, Curtis C, Blauw HM, van der

Kooi AJ, de Visser M, Goris A, Weber M, Shaw CE, Smith BN, Pansarasa O, Cereda C,

Del Bo R, Comi GP, D'Alfonso S, Bertolin C, Sorarù G, Mazzini L, Pensato V,

Gellera C, Tiloca C, Ratti A, Calvo A, Moglia C, Brunetti M, Arcuti S, Capozzo R,

Zecca C, Lunetta C, Penco S, Riva N, Padovani A, Filosto M, Muller B, Stuit RJ;

PARALS Registry; SLALOM Group; SLAP Registry; FALS Sequencing Consortium; SLAGEN

Consortium; NNIPPS Study Group, Blair I, Zhang K, McCann EP, Fifita JA, Nicholson

GA, Rowe DB, Pamphlett R, Kiernan MC, Grosskreutz J, Witte OW, Ringer T, Prell T,

Stubendorff B, Kurth I, Hübner CA, Leigh PN, Casale F, Chio A, Beghi E, Pupillo

E, Tortelli R, Logroscino G, Powell J, Ludolph AC, Weishaupt JH, Robberecht W,

Van Damme P, Franke L, Pers TH, Brown RH, Glass JD, Landers JE, Hardiman O,

Andersen PM, Corcia P, Vourc'h P, Silani V, Wray NR, Visscher PM, de Bakker PI,

van Es MA, Pasterkamp RJ, Lewis CM, Breen G, Al-Chalabi A, van den Berg LH,



Veldink JH. Genome-wide association analyses identify new risk variants and the

genetic architecture of amyotrophic lateral sclerosis. Nat Genet. 2016

Sep;48(9):1043-8. doi: 10.1038/ng.3622. Epub 2016 Jul 25. PubMed PMID: 27455348;


77: Panza F, Solfrizzi V, Seripa D, Imbimbo BP, Lozupone M, Santamato A, Zecca C,

Barulli MR, Bellomo A, Pilotto A, Daniele A, Greco A, Logroscino G. Tau-Centric

Targets and Drugs in Clinical Development for the Treatment of Alzheimer's

Disease. Biomed Res Int. 2016;2016:3245935. doi: 10.1155/2016/3245935. Epub 2016

Jun 26. Review. PubMed PMID: 27429978; PubMed Central PMCID: PMC4939203.

78: Jellinger KA, Logroscino G, Rizzo G, Copetti M, Arcuti S, Martino D, Fontana

A. Accuracy of clinical diagnosis of Parkinson disease: A systematic review and

meta-analysis. Neurology. 2016 Jul 12;87(2):237-8. doi:

10.1212/WNL.0000000000002876. PubMed PMID: 27402941.

79: Panza F, Lozupone M, Stella E, Lofano L, Gravina C, Urbano M, Daniele A,

Bellomo A, Logroscino G, Greco A, Seripa D. Psychiatry meets pharmacogenetics for

the treatment of revolving door patients with psychiatric disorders. Expert Rev

Neurother. 2016 Dec;16(12):1357-1369. Epub 2016 Jul 11. Review. PubMed PMID:

27376791.

80: Pilotto A, Gallina P, Copetti M, Pilotto A, Marcato F, Mello AM, Simonato M,

Logroscino G, Padovani A, Ferrucci L, Panza F; Multidimensional Prognostic

Index_Age Project Investigators. Warfarin Treatment and All-Cause Mortality in

Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective

Observational Study. J Am Geriatr Soc. 2016 Jul;64(7):1416-24. doi:

10.1111/jgs.14221. Epub 2016 Jun 13. PubMed PMID: 27295351.

81: Daniele A, Panza F, Greco A, Logroscino G, Seripa D. Can a Positive

Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients

with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of

Parkinson's Disease. Parkinsons Dis. 2016;2016:2531812. doi:

10.1155/2016/2531812. Epub 2016 May 17. Review. PubMed PMID: 27293955; PubMed


82: Santamato A, Ranieri M, Solfrizzi V, Lozupone M, Vecchio M, Daniele A, Greco

A, Seripa D, Logroscino G, Panza F. High doses of incobotulinumtoxinA for the

treatment of post-stroke spasticity: are they safe and effective? Expert Opin

Drug Metab Toxicol. 2016 Aug;12(8):843-6. doi: 10.1080/17425255.2016.1198318.

Epub 2016 Jun 17. PubMed PMID: 27291256.

83: Sassi C, Capozzo R, Gibbs R, Crews C, Zecca C, Arcuti S, Copetti M, Barulli

MR, Brescia V, Singleton AB, Logroscino G. A Novel Splice-Acceptor Site Mutation

in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family

from Southern Italy. J Alzheimers Dis. 2016 May 30;53(2):475-85. doi:

10.3233/JAD-151170. PubMed PMID: 27258413.

84: Marin B, Boumédiene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL,

Copetti M, Preux PM, Beghi E. Variation in worldwide incidence of amyotrophic

lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017 Feb 1;46(1):57-74. doi:

10.1093/ije/dyw061. Review. PubMed PMID: 27185810; PubMed Central PMCID:

PMC5407171.

85: Borghero G, Pugliatti M, Marrosu F, Marrosu MG, Murru MR, Floris G, Cannas A,

Occhineri P, Cau TB, Loi D, Ticca A, Traccis S, Manera U, Canosa A, Moglia C,



Calvo A, Barberis M, Brunetti M, Gibbs JR, Renton AE, Errichiello E, Zoledziewska

M, Mulas A, Qian Y, Din J, Pliner HA, Traynor BJ, Chiò A; ITALSGEN and SARDINALS

Consortia. TBK1 is associated with ALS and ALS-FTD in Sardinian patients.

Neurobiol Aging. 2016 Jul;43:180.e1-5. doi: 10.1016/j.neurobiolaging.2016.03.028.

Epub 2016 Apr 9. PubMed PMID: 27156075.

86: Logroscino G, Panza F. The Role of Hearing Impairment in Cognitive Decline:

Need for the Special Sense Assessment in Evaluating Cognition In Older Age.

Neuroepidemiology. 2016;46(4):290-1. doi: 10.1159/000445988. Epub 2016 Apr 23.


87: Logroscino G, Del Tedesco F, Cambise C, Coraci D, Donati F, Santilli V, Padua

L. Fibular nerve palsy after hip replacement: Not only surgeon responsibility.

Hereditary neuropathy with liability to pressure palsies (HNPP) a rare cause of

nerve liability. Orthop Traumatol Surg Res. 2016 Jun;102(4):529-31. doi:

10.1016/j.otsr.2016.02.013. Epub 2016 Apr 12. PubMed PMID: 27084090.

88: Tortelli R, Copetti M, Panza F, Fontana A, Cortese R, Capozzo R, Introna A,

D'Errico E, Zoccolella S, Arcuti S, Seripa D, Simone IL, Logroscino G. Time to

generalization and prediction of survival in patients with amyotrophic lateral

sclerosis: a retrospective observational study. Eur J Neurol. 2016

Jun;23(6):1117-25. doi: 10.1111/ene.12994. Epub 2016 Mar 25. PubMed PMID:

27016147.

89: Babiloni C, Triggiani AI, Lizio R, Cordone S, Tattoli G, Bevilacqua V,

Soricelli A, Ferri R, Nobili F, Gesualdo L, Millán-Calenti JC, Buján A, Tortelli

R, Cardinali V, Barulli MR, Giannini A, Spagnolo P, Armenise S, Buenza G,

Scianatico G, Logroscino G, Frisoni GB, Del Percio C. Classification of Single

Normal and Alzheimer's Disease Individuals from Cortical Sources of Resting State

EEG Rhythms. Front Neurosci. 2016 Feb 23;10:47. doi: 10.3389/fnins.2016.00047.

eCollection 2016. PubMed PMID: 26941594; PubMed Central PMCID: PMC4763025.

90: Marin B, Arcuti S, Jesus P, Logroscino G, Copetti M, Fontana A, Nicol M,

Raymondeau M, Desport JC, Preux PM, Couratier P; French register of ALS in

Limousin (FRALim). Population-Based Evidence that Survival in Amyotrophic Lateral

Sclerosis is Related to Weight Loss at Diagnosis. Neurodegener Dis.

2016;16(3-4):225-34. doi: 10.1159/000442444. Epub 2016 Feb 12. PubMed PMID:

26866503.

91: Marin B, Beghi E, Vial C, Bernard E, Lautrette G, Clavelou P, Guy N, Lemasson

G, Debruxelles S, Cintas P, Antoine JC, Camdessanche JP, Logroscino G, Preux PM,

Couratier P; EURECALS consortium. Evaluation of the application of the European

guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis

(ALS) patients in six French ALS centres. Eur J Neurol. 2016 Apr;23(4):787-95.

doi: 10.1111/ene.12941. Epub 2016 Feb 1. PubMed PMID: 26833536.

92: Seripa D, Solfrizzi V, Imbimbo BP, Daniele A, Santamato A, Lozupone M,

Zuliani G, Greco A, Logroscino G, Panza F. Tau-directed approaches for the

treatment of Alzheimer's disease: focus on leuco-methylthioninium. Expert Rev

Neurother. 2016;16(3):259-77. doi: 10.1586/14737175.2016.1140039. Review. PubMed

PMID: 26822031.

93: Veneziani F, Panza F, Solfrizzi V, Capozzo R, Barulli MR, Leo A, Lozupone M,

Fontana A, Arcuti S, Copetti M, Cardinali V, Grasso A, Tursi M, Iurillo A,

Imbimbo BP, Seripa D, Logroscino G. Examination of level of knowledge in Italian



general practitioners attending an education session on diagnosis and management

of the early stage of Alzheimer's disease: pass or fail? Int Psychogeriatr. 2016

Jul;28(7):1111-24. doi: 10.1017/S1041610216000041. Epub 2016 Jan 28. PubMed PMID:

26817511.

94: Panza F, Seripa D, Solfrizzi V, Imbimbo BP, Santamato A, Lozupone M, Capozzo

R, Prete C, Pilotto A, Greco A, Logroscino G. Tau aggregation inhibitors: the

future of Alzheimer's pharmacotherapy? Expert Opin Pharmacother.

2016;17(4):457-61. doi: 10.1517/14656566.2016.1146686. Epub 2016 Feb 15. PubMed

PMID: 26809554.

95: Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G. Accuracy of

clinical diagnosis of Parkinson disease: A systematic review and meta-analysis.

Neurology. 2016 Feb 9;86(6):566-76. doi: 10.1212/WNL.0000000000002350. Epub 2016

Jan 13. Review. PubMed PMID: 26764028.

96: Chiò A, Mora G, Sabatelli M, Caponnetto C, Lunetta C, Traynor BJ, Johnson JO,

Nalls MA, Calvo A, Moglia C, Borghero G, Trojsi F, La Bella V, Volanti P, Simone

I, Salvi F, Logullo FO, Riva N, Carrera P, Giannini F, Mandrioli J, Tanel R,

Capasso M, Tremolizzo L, Battistini S, Murru MR, Origone P, Zollino M, Penco S;

ITALSGEN consortium; SARDINIALS consortium, Mazzini L, D'Alfonso S, Restagno G,

Brunetti M, Barberis M, Conforti FL. ATNX2 is not a regulatory gene in Italian

amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion. Neurobiol

Aging. 2016 Mar;39:218.e5-8. doi: 10.1016/j.neurobiolaging.2015.11.027. Epub 2015

Dec 8. PubMed PMID: 26733254; PubMed Central PMCID: PMC4775342.

97: Palmer SC, Ruospo M, Barulli MR, Iurillo A, Saglimbene V, Natale P, Gargano

L, Murgo AM, Loy C, van Zwieten A, Wong G, Tortelli R, Craig JC, Johnson DW,

Tonelli M, Hegbrant J, Wollheim C, Logroscino G, Strippoli GF; COGNITIVE-HD Study

Investigators. COGNITIVE-HD study: protocol of an observational study of

neurocognitive functioning and association with clinical outcomes in adults with

end-stage kidney disease treated with haemodialysis. BMJ Open. 2015 Dec

9;5(12):e009328. doi: 10.1136/bmjopen-2015-009328. PubMed PMID: 26656022; PubMed


98: Tortelli R, Copetti M, Arcuti S, Tursi M, Iurillo A, Barulli MR, Cortese R,

Capozzo R, D'Errico E, Marin B, Simone IL, Logroscino G. Pseudobulbar affect

(PBA) in an incident ALS cohort: results from the Apulia registry (SLAP). J

Neurol. 2016 Feb;263(2):316-321. doi: 10.1007/s00415-015-7981-3. Epub 2015 Nov

20. PubMed PMID: 26588919.

99: Marin B, Couratier P, Arcuti S, Copetti M, Fontana A, Nicol M, Raymondeau M,

Logroscino G, Preux PM. Stratification of ALS patients' survival: a

population-based study. J Neurol. 2016 Jan;263(1):100-11. doi:

10.1007/s00415-015-7940-z. Epub 2015 Oct 30. PubMed PMID: 26518423.

100: Marin B, Bianchi E, Pupillo E, Lunetta C, Tremolizzo L, Logroscino G, Chiò

A, Preux PM, Beghi E. Non-self-sufficiency as a primary outcome measure in ALS

trials. Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):77-84. doi:

10.3109/21678421.2015.1074704. Epub 2015 Oct 16. PubMed PMID: 26470831.

101: Marin B, Logroscino G, Boumédiene F, Labrunie A, Couratier P, Babron MC,

Leutenegger AL, Preux PM, Beghi E. Clinical and demographic factors and outcome

of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur

J Epidemiol. 2016 Mar;31(3):229-45. doi: 10.1007/s10654-015-0090-x. Epub 2015 Oct




102: Solfrizzi V, Panza F, Imbimbo BP, D'Introno A, Galluzzo L, Gandin C,

Misciagna G, Guerra V, Osella A, Baldereschi M, Di Carlo A, Inzitari D, Seripa D,

Pilotto A, Sabbá C, Logroscino G, Scafato E; Italian Longitudinal Study on Aging

Working Group. Coffee Consumption Habits and the Risk of Mild Cognitive

Impairment: The Italian Longitudinal Study on Aging. J Alzheimers Dis.

2015;47(4):889-99. doi: 10.3233/JAD-150333. PubMed PMID: 26401769.

103: Panza F, Seripa D, Solfrizzi V, Tortelli R, Greco A, Pilotto A, Logroscino

G. Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single

Complex Phenotype. J Alzheimers Dis. 2015;47(4):793-813. doi: 10.3233/JAD-150358.


104: Bennett DA, Brayne C, Feigin VL, Barker-Collo S, Brainin M, Davis D, Gallo

V, Jetté N, Karch A, Kurtzke JF, Lavados PM, Logroscino G, Nagel G, Preux PM,

Rothwell PM, Svenson LW. Explanation and Elaboration of the Standards of

Reporting of Neurological Disorders Checklist: A Guideline for the Reporting of

Incidence and Prevalence Studies in Neuroepidemiology. Neuroepidemiology.

2015;45(2):113-37. doi: 10.1159/000439132. Epub 2015 Sep 22. PubMed PMID:

26390430.

105: Panza F, Solfrizzi V, Seripa D, Imbimbo BP, Santamato A, Lozupone M, Prete

C, Greco A, Pilotto A, Logroscino G. Progresses in treating agitation: a major

clinical challenge in Alzheimer's disease. Expert Opin Pharmacother.

2015;16(17):2581-8. doi: 10.1517/14656566.2015.1092520. Epub 2015 Sep 21. Review.


106: GBD 2013 Risk Factors Collaborators, Forouzanfar MH, Alexander L, Anderson

HR, Bachman VF, Biryukov S, Brauer M, Burnett R, Casey D, Coates MM, Cohen A,

Delwiche K, Estep K, Frostad JJ, Astha KC, Kyu HH, Moradi-Lakeh M, Ng M, Slepak

EL, Thomas BA, Wagner J, Aasvang GM, Abbafati C, Abbasoglu Ozgoren A, Abd-Allah

F, Abera SF, Aboyans V, Abraham B, Abraham JP, Abubakar I, Abu-Rmeileh NM, Aburto

TC, Achoki T, Adelekan A, Adofo K, Adou AK, Adsuar JC, Afshin A, Agardh EE, Al

Khabouri MJ, Al Lami FH, Alam SS, Alasfoor D, Albittar MI, Alegretti MA, Aleman

AV, Alemu ZA, Alfonso-Cristancho R, Alhabib S, Ali R, Ali MK, Alla F, Allebeck P,

Allen PJ, Alsharif U, Alvarez E, Alvis-Guzman N, Amankwaa AA, Amare AT, Ameh EA,

Ameli O, Amini H, Ammar W, Anderson BO, Antonio CA, Anwari P, Argeseanu

Cunningham S, Arnlöv J, Arsenijevic VS, Artaman A, Asghar RJ, Assadi R, Atkins

LS, Atkinson C, Avila MA, Awuah B, Badawi A, Bahit MC, Bakfalouni T, Balakrishnan

K, Balalla S, Balu RK, Banerjee A, Barber RM, Barker-Collo SL, Barquera S,

Barregard L, Barrero LH, Barrientos-Gutierrez T, Basto-Abreu AC, Basu A, Basu S,

Basulaiman MO, Batis Ruvalcaba C, Beardsley J, Bedi N, Bekele T, Bell ML, Benjet

C, Bennett DA, Benzian H, Bernabé E, Beyene TJ, Bhala N, Bhalla A, Bhutta ZA,

Bikbov B, Bin Abdulhak AA, Blore JD, Blyth FM, Bohensky MA, Bora Başara B, Borges

G, Bornstein NM, Bose D, Boufous S, Bourne RR, Brainin M, Brazinova A, Breitborde

NJ, Brenner H, Briggs AD, Broday DM, Brooks PM, Bruce NG, Brugha TS, Brunekreef

B, Buchbinder R, Bui LN, Bukhman G, Bulloch AG, Burch M, Burney PG, Campos-Nonato

IR, Campuzano JC, Cantoral AJ, Caravanos J, Cárdenas R, Cardis E, Carpenter DO,

Caso V, Castañeda-Orjuela CA, Castro RE, Catalá-López F, Cavalleri F, Çavlin A,

Chadha VK, Chang JC, Charlson FJ, Chen H, Chen W, Chen Z, Chiang PP, Chimed-Ochir

O, Chowdhury R, Christophi CA, Chuang TW, Chugh SS, Cirillo M, Claßen TK,



Colistro V, Colomar M, Colquhoun SM, Contreras AG, Cooper C, Cooperrider K,

Cooper LT, Coresh J, Courville KJ, Criqui MH, Cuevas-Nasu L, Damsere-Derry J,

Danawi H, Dandona L, Dandona R, Dargan PI, Davis A, Davitoiu DV, Dayama A, de

Castro EF, De la Cruz-Góngora V, De Leo D, de Lima G, Degenhardt L, del Pozo-Cruz

B, Dellavalle RP, Deribe K, Derrett S, Des Jarlais DC, Dessalegn M, deVeber GA,

Devries KM, Dharmaratne SD, Dherani MK, Dicker D, Ding EL, Dokova K, Dorsey ER,

Driscoll TR, Duan L, Durrani AM, Ebel BE, Ellenbogen RG, Elshrek YM, Endres M,

Ermakov SP, Erskine HE, Eshrati B, Esteghamati A, Fahimi S, Faraon EJ, Farzadfar

F, Fay DF, Feigin VL, Feigl AB, Fereshtehnejad SM, Ferrari AJ, Ferri CP, Flaxman

AD, Fleming TD, Foigt N, Foreman KJ, Paleo UF, Franklin RC, Gabbe B, Gaffikin L,

Gakidou E, Gamkrelidze A, Gankpé FG, Gansevoort RT, García-Guerra FA, Gasana E,

Geleijnse JM, Gessner BD, Gething P, Gibney KB, Gillum RF, Ginawi IA, Giroud M,

Giussani G, Goenka S, Goginashvili K, Gomez Dantes H, Gona P, Gonzalez de Cosio

T, González-Castell D, Gotay CC, Goto A, Gouda HN, Guerrant RL, Gugnani HC,

Guillemin F, Gunnell D, Gupta R, Gupta R, Gutiérrez RA, Hafezi-Nejad N, Hagan H,

Hagstromer M, Halasa YA, Hamadeh RR, Hammami M, Hankey GJ, Hao Y, Harb HL, Haregu

TN, Haro JM, Havmoeller R, Hay SI, Hedayati MT, Heredia-Pi IB, Hernandez L,

Heuton KR, Heydarpour P, Hijar M, Hoek HW, Hoffman HJ, Hornberger JC, Hosgood HD,

Hoy DG, Hsairi M, Hu G, Hu H, Huang C, Huang JJ, Hubbell BJ, Huiart L, Husseini

A, Iannarone ML, Iburg KM, Idrisov BT, Ikeda N, Innos K, Inoue M, Islami F,

Ismayilova S, Jacobsen KH, Jansen HA, Jarvis DL, Jassal SK, Jauregui A, Jayaraman

S, Jeemon P, Jensen PN, Jha V, Jiang F, Jiang G, Jiang Y, Jonas JB, Juel K, Kan

H, Kany Roseline SS, Karam NE, Karch A, Karema CK, Karthikeyan G, Kaul A,

Kawakami N, Kazi DS, Kemp AH, Kengne AP, Keren A, Khader YS, Khalifa SE, Khan EA,

Khang YH, Khatibzadeh S, Khonelidze I, Kieling C, Kim D, Kim S, Kim Y, Kimokoti

RW, Kinfu Y, Kinge JM, Kissela BM, Kivipelto M, Knibbs LD, Knudsen AK, Kokubo Y,

Kose MR, Kosen S, Kraemer A, Kravchenko M, Krishnaswami S, Kromhout H, Ku T,

Kuate Defo B, Kucuk Bicer B, Kuipers EJ, Kulkarni C, Kulkarni VS, Kumar GA, Kwan

GF, Lai T, Lakshmana Balaji A, Lalloo R, Lallukka T, Lam H, Lan Q, Lansingh VC,

Larson HJ, Larsson A, Laryea DO, Lavados PM, Lawrynowicz AE, Leasher JL, Lee JT,

Leigh J, Leung R, Levi M, Li Y, Li Y, Liang J, Liang X, Lim SS, Lindsay MP,

Lipshultz SE, Liu S, Liu Y, Lloyd BK, Logroscino G, London SJ, Lopez N,

Lortet-Tieulent J, Lotufo PA, Lozano R, Lunevicius R, Ma J, Ma S, Machado VM,

MacIntyre MF, Magis-Rodriguez C, Mahdi AA, Majdan M, Malekzadeh R, Mangalam S,

Mapoma CC, Marape M, Marcenes W, Margolis DJ, Margono C, Marks GB, Martin RV,

Marzan MB, Mashal MT, Masiye F, Mason-Jones AJ, Matsushita K, Matzopoulos R,

Mayosi BM, Mazorodze TT, McKay AC, McKee M, McLain A, Meaney PA, Medina C,

Mehndiratta MM, Mejia-Rodriguez F, Mekonnen W, Melaku YA, Meltzer M, Memish ZA,

Mendoza W, Mensah GA, Meretoja A, Mhimbira FA, Micha R, Miller TR, Mills EJ,

Misganaw A, Mishra S, Mohamed Ibrahim N, Mohammad KA, Mokdad AH, Mola GL, Monasta

L, Montañez Hernandez JC, Montico M, Moore AR, Morawska L, Mori R, Moschandreas

J, Moturi WN, Mozaffarian D, Mueller UO, Mukaigawara M, Mullany EC, Murthy KS,

Naghavi M, Nahas Z, Naheed A, Naidoo KS, Naldi L, Nand D, Nangia V, Narayan KM,

Nash D, Neal B, Nejjari C, Neupane SP, Newton CR, Ngalesoni FN, Ngirabega Jde D,

Nguyen G, Nguyen NT, Nieuwenhuijsen MJ, Nisar MI, Nogueira JR, Nolla JM, Nolte S,

Norheim OF, Norman RE, Norrving B, Nyakarahuka L, Oh IH, Ohkubo T, Olusanya BO,

Omer SB, Opio JN, Orozco R, Pagcatipunan RS Jr, Pain AW, Pandian JD, Panelo CI,



Papachristou C, Park EK, Parry CD, Paternina Caicedo AJ, Patten SB, Paul VK,

Pavlin BI, Pearce N, Pedraza LS, Pedroza A, Pejin Stokic L, Pekericli A, Pereira

DM, Perez-Padilla R, Perez-Ruiz F, Perico N, Perry SA, Pervaiz A, Pesudovs K,

Peterson CB, Petzold M, Phillips MR, Phua HP, Plass D, Poenaru D, Polanczyk GV,

Polinder S, Pond CD, Pope CA, Pope D, Popova S, Pourmalek F, Powles J,

Prabhakaran D, Prasad NM, Qato DM, Quezada AD, Quistberg DA, Racapé L, Rafay A,

Rahimi K, Rahimi-Movaghar V, Rahman SU, Raju M, Rakovac I, Rana SM, Rao M, Razavi

H, Reddy KS, Refaat AH, Rehm J, Remuzzi G, Ribeiro AL, Riccio PM, Richardson L,

Riederer A, Robinson M, Roca A, Rodriguez A, Rojas-Rueda D, Romieu I, Ronfani L,

Room R, Roy N, Ruhago GM, Rushton L, Sabin N, Sacco RL, Saha S, Sahathevan R,

Sahraian MA, Salomon JA, Salvo D, Sampson UK, Sanabria JR, Sanchez LM,

Sánchez-Pimienta TG, Sanchez-Riera L, Sandar L, Santos IS, Sapkota A, Satpathy M,

Saunders JE, Sawhney M, Saylan MI, Scarborough P, Schmidt JC, Schneider IJ,

Schöttker B, Schwebel DC, Scott JG, Seedat S, Sepanlou SG, Serdar B, Servan-Mori

EE, Shaddick G, Shahraz S, Levy TS, Shangguan S, She J, Sheikhbahaei S, Shibuya

K, Shin HH, Shinohara Y, Shiri R, Shishani K, Shiue I, Sigfusdottir ID,

Silberberg DH, Simard EP, Sindi S, Singh A, Singh GM, Singh JA, Skirbekk V, Sliwa

K, Soljak M, Soneji S, Søreide K, Soshnikov S, Sposato LA, Sreeramareddy CT,

Stapelberg NJ, Stathopoulou V, Steckling N, Stein DJ, Stein MB, Stephens N,

Stöckl H, Straif K, Stroumpoulis K, Sturua L, Sunguya BF, Swaminathan S, Swaroop

M, Sykes BL, Tabb KM, Takahashi K, Talongwa RT, Tandon N, Tanne D, Tanner M,

Tavakkoli M, Te Ao BJ, Teixeira CM, Téllez Rojo MM, Terkawi AS,

Texcalac-Sangrador JL, Thackway SV, Thomson B, Thorne-Lyman AL, Thrift AG,

Thurston GD, Tillmann T, Tobollik M, Tonelli M, Topouzis F, Towbin JA, Toyoshima

H, Traebert J, Tran BX, Trasande L, Trillini M, Trujillo U, Dimbuene ZT,

Tsilimbaris M, Tuzcu EM, Uchendu US, Ukwaja KN, Uzun SB, van de Vijver S, Van

Dingenen R, van Gool CH, van Os J, Varakin YY, Vasankari TJ, Vasconcelos AM,

Vavilala MS, Veerman LJ, Velasquez-Melendez G, Venketasubramanian N, Vijayakumar

L, Villalpando S, Violante FS, Vlassov VV, Vollset SE, Wagner GR, Waller SG,

Wallin MT, Wan X, Wang H, Wang J, Wang L, Wang W, Wang Y, Warouw TS, Watts CH,

Weichenthal S, Weiderpass E, Weintraub RG, Werdecker A, Wessells KR, Westerman R,

Whiteford HA, Wilkinson JD, Williams HC, Williams TN, Woldeyohannes SM, Wolfe CD,

Wong JQ, Woolf AD, Wright JL, Wurtz B, Xu G, Yan LL, Yang G, Yano Y, Ye P,

Yenesew M, Yentür GK, Yip P, Yonemoto N, Yoon SJ, Younis MZ, Younoussi Z, Yu C,

Zaki ME, Zhao Y, Zheng Y, Zhou M, Zhu J, Zhu S, Zou X, Zunt JR, Lopez AD, Vos T,

Murray CJ. Global, regional, and national comparative risk assessment of 79

behavioural, environmental and occupational, and metabolic risks or clusters of

risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of

Disease Study 2013. Lancet. 2015 Dec 5;386(10010):2287-323. doi:

10.1016/S0140-6736(15)00128-2. Epub 2015 Sep 11. PubMed PMID: 26364544; PubMed


107: Barulli MR, Fontana A, Panza F, Copetti M, Bruno S, Tursi M, Iurillo A,

Tortelli R, Capozzo R, Simone IL, Logroscino G. Frontal assessment battery for

detecting executive dysfunction in amyotrophic lateral sclerosis without

dementia: a retrospective observational study. BMJ Open. 2015 Sep 3;5(9):e007069.

doi: 10.1136/bmjopen-2014-007069. PubMed PMID: 26338835; PubMed Central PMCID:

PMC4563243.



108: Benedetti MD, Pugliatti M, D'Alessandro R, Beghi E, Chiò A, Logroscino G,

Filippini G, Galeotti F, Massari M, Santuccio C, Raschetti R; ITANG Study Group.

A Multicentric Prospective Incidence Study of Guillain-Barré Syndrome in Italy.

The ITANG Study. Neuroepidemiology. 2015;45(2):90-9. doi: 10.1159/000438752. Epub

2015 Aug 29. PubMed PMID: 26329724.

109: GBD 2013 DALYs and HALE Collaborators, Murray CJ, Barber RM, Foreman KJ,

Abbasoglu Ozgoren A, Abd-Allah F, Abera SF, Aboyans V, Abraham JP, Abubakar I,

Abu-Raddad LJ, Abu-Rmeileh NM, Achoki T, Ackerman IN, Ademi Z, Adou AK, Adsuar

JC, Afshin A, Agardh EE, Alam SS, Alasfoor D, Albittar MI, Alegretti MA, Alemu

ZA, Alfonso-Cristancho R, Alhabib S, Ali R, Alla F, Allebeck P, Almazroa MA,

Alsharif U, Alvarez E, Alvis-Guzman N, Amare AT, Ameh EA, Amini H, Ammar W,

Anderson HR, Anderson BO, Antonio CA, Anwari P, Arnlöv J, Arsic Arsenijevic VS,

Artaman A, Asghar RJ, Assadi R, Atkins LS, Avila MA, Awuah B, Bachman VF, Badawi

A, Bahit MC, Balakrishnan K, Banerjee A, Barker-Collo SL, Barquera S, Barregard

L, Barrero LH, Basu A, Basu S, Basulaiman MO, Beardsley J, Bedi N, Beghi E,

Bekele T, Bell ML, Benjet C, Bennett DA, Bensenor IM, Benzian H, Bernabé E,

Bertozzi-Villa A, Beyene TJ, Bhala N, Bhalla A, Bhutta ZA, Bienhoff K, Bikbov B,

Biryukov S, Blore JD, Blosser CD, Blyth FM, Bohensky MA, Bolliger IW, Bora Başara

B, Bornstein NM, Bose D, Boufous S, Bourne RR, Boyers LN, Brainin M, Brayne CE,

Brazinova A, Breitborde NJ, Brenner H, Briggs AD, Brooks PM, Brown JC, Brugha TS,

Buchbinder R, Buckle GC, Budke CM, Bulchis A, Bulloch AG, Campos-Nonato IR,

Carabin H, Carapetis JR, Cárdenas R, Carpenter DO, Caso V, Castañeda-Orjuela CA,

Castro RE, Catalá-López F, Cavalleri F, Çavlin A, Chadha VK, Chang JC, Charlson

FJ, Chen H, Chen W, Chiang PP, Chimed-Ochir O, Chowdhury R, Christensen H,

Christophi CA, Cirillo M, Coates MM, Coffeng LE, Coggeshall MS, Colistro V,

Colquhoun SM, Cooke GS, Cooper C, Cooper LT, Coppola LM, Cortinovis M, Criqui MH,

Crump JA, Cuevas-Nasu L, Danawi H, Dandona L, Dandona R, Dansereau E, Dargan PI,

Davey G, Davis A, Davitoiu DV, Dayama A, De Leo D, Degenhardt L, Del Pozo-Cruz B,

Dellavalle RP, Deribe K, Derrett S, Des Jarlais DC, Dessalegn M, Dharmaratne SD,

Dherani MK, Diaz-Torné C, Dicker D, Ding EL, Dokova K, Dorsey ER, Driscoll TR,

Duan L, Duber HC, Ebel BE, Edmond KM, Elshrek YM, Endres M, Ermakov SP, Erskine

HE, Eshrati B, Esteghamati A, Estep K, Faraon EJ, Farzadfar F, Fay DF, Feigin VL,

Felson DT, Fereshtehnejad SM, Fernandes JG, Ferrari AJ, Fitzmaurice C, Flaxman

AD, Fleming TD, Foigt N, Forouzanfar MH, Fowkes FG, Paleo UF, Franklin RC, Fürst

T, Gabbe B, Gaffikin L, Gankpé FG, Geleijnse JM, Gessner BD, Gething P, Gibney

KB, Giroud M, Giussani G, Gomez Dantes H, Gona P, González-Medina D, Gosselin RA,

Gotay CC, Goto A, Gouda HN, Graetz N, Gugnani HC, Gupta R, Gupta R, Gutiérrez RA,

Haagsma J, Hafezi-Nejad N, Hagan H, Halasa YA, Hamadeh RR, Hamavid H, Hammami M,

Hancock J, Hankey GJ, Hansen GM, Hao Y, Harb HL, Haro JM, Havmoeller R, Hay SI,

Hay RJ, Heredia-Pi IB, Heuton KR, Heydarpour P, Higashi H, Hijar M, Hoek HW,

Hoffman HJ, Hosgood HD, Hossain M, Hotez PJ, Hoy DG, Hsairi M, Hu G, Huang C,

Huang JJ, Husseini A, Huynh C, Iannarone ML, Iburg KM, Innos K, Inoue M, Islami

F, Jacobsen KH, Jarvis DL, Jassal SK, Jee SH, Jeemon P, Jensen PN, Jha V, Jiang

G, Jiang Y, Jonas JB, Juel K, Kan H, Karch A, Karema CK, Karimkhani C,

Karthikeyan G, Kassebaum NJ, Kaul A, Kawakami N, Kazanjan K, Kemp AH, Kengne AP,

Keren A, Khader YS, Khalifa SE, Khan EA, Khan G, Khang YH, Kieling C, Kim D, Kim

S, Kim Y, Kinfu Y, Kinge JM, Kivipelto M, Knibbs LD, Knudsen AK, Kokubo Y, Kosen



S, Krishnaswami S, Kuate Defo B, Kucuk Bicer B, Kuipers EJ, Kulkarni C, Kulkarni

VS, Kumar GA, Kyu HH, Lai T, Lalloo R, Lallukka T, Lam H, Lan Q, Lansingh VC,

Larsson A, Lawrynowicz AE, Leasher JL, Leigh J, Leung R, Levitz CE, Li B, Li Y,

Li Y, Lim SS, Lind M, Lipshultz SE, Liu S, Liu Y, Lloyd BK, Lofgren KT,

Logroscino G, Looker KJ, Lortet-Tieulent J, Lotufo PA, Lozano R, Lucas RM,

Lunevicius R, Lyons RA, Ma S, Macintyre MF, Mackay MT, Majdan M, Malekzadeh R,

Marcenes W, Margolis DJ, Margono C, Marzan MB, Masci JR, Mashal MT, Matzopoulos

R, Mayosi BM, Mazorodze TT, Mcgill NW, Mcgrath JJ, Mckee M, Mclain A, Meaney PA,

Medina C, Mehndiratta MM, Mekonnen W, Melaku YA, Meltzer M, Memish ZA, Mensah GA,

Meretoja A, Mhimbira FA, Micha R, Miller TR, Mills EJ, Mitchell PB, Mock CN,

Mohamed Ibrahim N, Mohammad KA, Mokdad AH, Mola GL, Monasta L, Montañez Hernandez

JC, Montico M, Montine TJ, Mooney MD, Moore AR, Moradi-Lakeh M, Moran AE, Mori R,

Moschandreas J, Moturi WN, Moyer ML, Mozaffarian D, Msemburi WT, Mueller UO,

Mukaigawara M, Mullany EC, Murdoch ME, Murray J, Murthy KS, Naghavi M, Naheed A,

Naidoo KS, Naldi L, Nand D, Nangia V, Narayan KM, Nejjari C, Neupane SP, Newton

CR, Ng M, Ngalesoni FN, Nguyen G, Nisar MI, Nolte S, Norheim OF, Norman RE,

Norrving B, Nyakarahuka L, Oh IH, Ohkubo T, Ohno SL, Olusanya BO, Opio JN,

Ortblad K, Ortiz A, Pain AW, Pandian JD, Panelo CI, Papachristou C, Park EK, Park

JH, Patten SB, Patton GC, Paul VK, Pavlin BI, Pearce N, Pereira DM, Perez-Padilla

R, Perez-Ruiz F, Perico N, Pervaiz A, Pesudovs K, Peterson CB, Petzold M,

Phillips MR, Phillips BK, Phillips DE, Piel FB, Plass D, Poenaru D, Polinder S,

Pope D, Popova S, Poulton RG, Pourmalek F, Prabhakaran D, Prasad NM, Pullan RL,

Qato DM, Quistberg DA, Rafay A, Rahimi K, Rahman SU, Raju M, Rana SM, Razavi H,

Reddy KS, Refaat A, Remuzzi G, Resnikoff S, Ribeiro AL, Richardson L, Richardus

JH, Roberts DA, Rojas-Rueda D, Ronfani L, Roth GA, Rothenbacher D, Rothstein DH,

Rowley JT, Roy N, Ruhago GM, Saeedi MY, Saha S, Sahraian MA, Sampson UK, Sanabria

JR, Sandar L, Santos IS, Satpathy M, Sawhney M, Scarborough P, Schneider IJ,

Schöttker B, Schumacher AE, Schwebel DC, Scott JG, Seedat S, Sepanlou SG, Serina

PT, Servan-Mori EE, Shackelford KA, Shaheen A, Shahraz S, Shamah Levy T,

Shangguan S, She J, Sheikhbahaei S, Shi P, Shibuya K, Shinohara Y, Shiri R,

Shishani K, Shiue I, Shrime MG, Sigfusdottir ID, Silberberg DH, Simard EP, Sindi

S, Singh A, Singh JA, Singh L, Skirbekk V, Slepak EL, Sliwa K, Soneji S, Søreide

K, Soshnikov S, Sposato LA, Sreeramareddy CT, Stanaway JD, Stathopoulou V, Stein

DJ, Stein MB, Steiner C, Steiner TJ, Stevens A, Stewart A, Stovner LJ,

Stroumpoulis K, Sunguya BF, Swaminathan S, Swaroop M, Sykes BL, Tabb KM,

Takahashi K, Tandon N, Tanne D, Tanner M, Tavakkoli M, Taylor HR, Te Ao BJ,

Tediosi F, Temesgen AM, Templin T, Ten Have M, Tenkorang EY, Terkawi AS, Thomson

B, Thorne-Lyman AL, Thrift AG, Thurston GD, Tillmann T, Tonelli M, Topouzis F,

Toyoshima H, Traebert J, Tran BX, Trillini M, Truelsen T, Tsilimbaris M, Tuzcu

EM, Uchendu US, Ukwaja KN, Undurraga EA, Uzun SB, Van Brakel WH, Van De Vijver S,

van Gool CH, Van Os J, Vasankari TJ, Venketasubramanian N, Violante FS, Vlassov

VV, Vollset SE, Wagner GR, Wagner J, Waller SG, Wan X, Wang H, Wang J, Wang L,

Warouw TS, Weichenthal S, Weiderpass E, Weintraub RG, Wenzhi W, Werdecker A,

Westerman R, Whiteford HA, Wilkinson JD, Williams TN, Wolfe CD, Wolock TM, Woolf

AD, Wulf S, Wurtz B, Xu G, Yan LL, Yano Y, Ye P, Yentür GK, Yip P, Yonemoto N,

Yoon SJ, Younis MZ, Yu C, Zaki ME, Zhao Y, Zheng Y, Zonies D, Zou X, Salomon JA,

Lopez AD, Vos T. Global, regional, and national disability-adjusted life years



(DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188

countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015

Nov 28;386(10009):2145-91. doi: 10.1016/S0140-6736(15)61340-X. Epub 2015 Aug 28.


110: Logroscino G. Motor neuron disease: Are diabetes and amyotrophic lateral

sclerosis related? Nat Rev Neurol. 2015 Sep;11(9):488-90. doi:

10.1038/nrneurol.2015.145. Epub 2015 Aug 18. PubMed PMID: 26281962.

111: Santamato A, Micello MF, Valeno G, Beatrice R, Cinone N, Baricich A, Picelli

A, Panza F, Logroscino G, Fiore P, Ranieri M. Ultrasound-Guided Injection of

Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review

of the Literature. Toxins (Basel). 2015 Aug 10;7(8):3045-56. doi:

10.3390/toxins7083045. Review. PubMed PMID: 26266421; PubMed Central PMCID:

PMC4549739.

112: Borghero G, Pugliatti M, Marrosu F, Marrosu MG, Murru MR, Floris G, Cannas

A, Parish LD, Cau TB, Loi D, Ticca A, Traccis S, Manera U, Canosa A, Moglia C,

Calvo A, Barberis M, Brunetti M, Renton AE, Nalls MA, Traynor BJ, Restagno G,

Chiò A; ITALSGEN and SARDINALS consortia. ATXN2 is a modifier of phenotype in ALS

patients of Sardinian ancestry. Neurobiol Aging. 2015 Oct;36(10):2906.e1-5. doi:

10.1016/j.neurobiolaging.2015.06.013. Epub 2015 Jun 25. PubMed PMID: 26208502;


113: Logroscino G. A community study outlines how to prevent Parkinson's disease

motor complications in the clinic. Eur J Neurol. 2016 Feb;23(2):231-2. doi:

10.1111/ene.12773. Epub 2015 Jul 15. PubMed PMID: 26177048.

114: Chiò A, Mora G, Sabatelli M, Caponnetto C, Lunetta C, Traynor BJ, Johnson

JO, Nalls MA, Calvo A, Moglia C, Borghero G, Monsurrò MR, La Bella V, Volanti P,

Simone I, Salvi F, Logullo FO, Nilo R, Giannini F, Mandrioli J, Tanel R, Murru

MR, Mandich P, Zollino M, Conforti FL, Penco S; ITALSGEN consortium; SARDINIALS

consortium, Brunetti M, Barberis M, Restagno G. HFE p.H63D polymorphism does not

influence ALS phenotype and survival. Neurobiol Aging. 2015

Oct;36(10):2906.e7-11. doi: 10.1016/j.neurobiolaging.2015.06.016. Epub 2015 Jun




Rothwell PM, Svenson LW. Development of the Standards of Reporting of

Neurological Disorders (STROND) checklist: A guideline for the reporting of

incidence and prevalence studies in neuroepidemiology. Neurology. 2015 Sep

1;85(9):821-8. doi: 10.1212/WNL.0000000000001866. Epub 2015 Jul 10. PubMed PMID:

26163431.

116: Panza F, Solfrizzi V, Seripa D, Imbimbo BP, Capozzo R, Quaranta N, Pilotto

A, Logroscino G. Age-related hearing impairment and frailty in Alzheimer's

disease: interconnected associations and mechanisms. Front Aging Neurosci. 2015

Jun 9;7:113. doi: 10.3389/fnagi.2015.00113. eCollection 2015. PubMed PMID:




Rothwell PM, Svenson LW. Development of the standards of reporting of

neurological disorders (STROND) checklist: a guideline for the reporting of



incidence and prevalence studies in neuroepidemiology. Eur J Epidemiol. 2015

Jul;30(7):569-76. doi: 10.1007/s10654-015-0034-5. Epub 2015 Jun 19. PubMed PMID:

26088602.

118: Global Burden of Disease Study 2013 Collaborators. Global, regional, and

national incidence, prevalence, and years lived with disability for 301 acute and

chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis

for the Global Burden of Disease Study 2013. Lancet. 2015 Aug

22;386(9995):743-800. doi: 10.1016/S0140-6736(15)60692-4. Epub 2015 Jun 7.

Review. PubMed PMID: 26063472; PubMed Central PMCID: PMC4561509.

119: Tortelli R, Copetti M, Panza F, Cortese R, Capozzo R, D'Errico E, Fontana A,

Simone IL, Logroscino G. Time to generalisation as a predictor of prognosis in

amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2016

Jun;87(6):678-9. doi: 10.1136/jnnp-2014-308478. Epub 2015 May 20. PubMed PMID:

25995485.

120: Tramacere I, Dalla Bella E, Chiò A, Mora G, Filippini G, Lauria G; EPOS

Trial Study Group. The MITOS system predicts long-term survival in amyotrophic

lateral sclerosis. J Neurol Neurosurg Psychiatry. 2015 Nov;86(11):1180-5. doi:

10.1136/jnnp-2014-310176. Epub 2015 Apr 17. PubMed PMID: 25886781.

121: Panza F, Solfrizzi V, Barulli MR, Santamato A, Seripa D, Pilotto A,

Logroscino G. Cognitive Frailty: A Systematic Review of Epidemiological and

Neurobiological Evidence of an Age-Related Clinical Condition. Rejuvenation Res.

2015 Oct;18(5):389-412. doi: 10.1089/rej.2014.1637. Epub 2015 Aug 20. Review.


122: Pisa FE, Logroscino G, Casetta A, Cecotti L, Verriello L, Bratina A, Sartori

A, Lazzarino de Lorenzo L, Eleopra R, Barbone F. The Use of Antidepressant

Medication before and after the Diagnosis of Amyotrophic Lateral Sclerosis: A

Population-Based Cohort Study. Neuroepidemiology. 2015;44(2):91-8. doi:

10.1159/000374119. Epub 2015 Mar 5. PubMed PMID: 25765191.

123: Panza F, Solfrizzi V, Barulli MR, Bonfiglio C, Guerra V, Osella A, Seripa D,

Sabbà C, Pilotto A, Logroscino G. Coffee, tea, and caffeine consumption and

prevention of late-life cognitive decline and dementia: a systematic review. J

Nutr Health Aging. 2015 Mar;19(3):313-28. doi: 10.1007/s12603-014-0563-8. Review.


124: Panza F, Solfrizzi V, Logroscino G. Age-related hearing impairment-a risk

factor and frailty marker for dementia and AD. Nat Rev Neurol. 2015

Mar;11(3):166-75. doi: 10.1038/nrneurol.2015.12. Epub 2015 Feb 17. Review. PubMed

PMID: 25686757.

125: Santamato A, Micello MF, Ranieri M, Valeno G, Albano A, Baricich A, Cisari

C, Intiso D, Pilotto A, Logroscino G, Panza F. Employment of higher doses of

botulinum toxin type A to reduce spasticity after stroke. J Neurol Sci. 2015 Mar

15;350(1-2):1-6. doi: 10.1016/j.jns.2015.01.033. Epub 2015 Feb 7. Review. PubMed

PMID: 25684341.

126: Lauria G, Dalla Bella E, Antonini G, Borghero G, Capasso M, Caponnetto C,

Chiò A, Corbo M, Eleopra R, Fazio R, Filosto M, Giannini F, Granieri E, La Bella

V, Logroscino G, Mandrioli J, Mazzini L, Monsurrò MR, Mora G, Pietrini V,

Quatrale R, Rizzi R, Salvi F, Siciliano G, Sorarù G, Volanti P, Tramacere I,

Filippini G; EPOS Trial Study Group. Erythropoietin in amyotrophic lateral



sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III

study. J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):879-86. doi:

10.1136/jnnp-2014-308996. Epub 2015 Jan 16. PubMed PMID: 25595151; PubMed Central

PMCID: PMC4515982.

127: GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and

national age-sex specific all-cause and cause-specific mortality for 240 causes

of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study

2013. Lancet. 2015 Jan 10;385(9963):117-71. doi: 10.1016/S0140-6736(14)61682-2.

Epub 2014 Dec 18. PubMed PMID: 25530442; PubMed Central PMCID: PMC4340604.

128: Capozzo R, Quaranta VN, Pellegrini F, Fontana A, Copetti M, Carratù P, Panza

F, Cassano A, Falcone VA, Tortelli R, Cortese R, Simone IL, Resta O, Logroscino

G. Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or

death in amyotrophic lateral sclerosis. J Neurol. 2015 Mar;262(3):593-603. doi:

10.1007/s00415-014-7613-3. Epub 2014 Dec 19. PubMed PMID: 25522696.

129: Capozzo R, Rizzo G, De Mari M, Tortorella C, Logroscino G. Early and severe

autonomic failure: broadening the clinical phenotype of type-2 spinocerebellar

ataxia. A case report. J Neurol. 2015 Jan;262(1):224-5. doi:

10.1007/s00415-014-7577-3. Epub 2014 Nov 20. PubMed PMID: 25408369.

130: Logroscino G, Ludolph A. Amyotrophic lateral sclerosis: new ideas from

cancer. Lancet Neurol. 2014 Nov;13(11):1067-1068. doi:

10.1016/S1474-4422(14)70177-2. Epub 2014 Oct 7. PubMed PMID: 25300935.

131: Santamato A, Micello MF, Panza F, Fortunato F, Baricich A, Cisari C, Pilotto

A, Logroscino G, Fiore P, Ranieri M. Can botulinum toxin type A injection

technique influence the clinical outcome of patients with post-stroke upper limb

spasticity? A randomized controlled trial comparing manual needle placement and

ultrasound-guided injection techniques. J Neurol Sci. 2014 Dec 15;347(1-2):39-43.

doi: 10.1016/j.jns.2014.09.016. Epub 2014 Sep 19. PubMed PMID: 25263601.

132: Panza F, Solfrizzi V, Giannini M, Seripa D, Pilotto A, Logroscino G.

Nutrition, frailty, and Alzheimer's disease. Front Aging Neurosci. 2014 Aug

26;6:221. doi: 10.3389/fnagi.2014.00221. eCollection 2014. PubMed PMID: 25206332;


133: Lucca U, Tettamanti M, Logroscino G, Tiraboschi P, Landi C, Sacco L, Garrì

M, Ammesso S, Bertinotti C, Biotti A, Gargantini E, Piedicorcia A, Nobili A,

Pasina L, Franchi C, Djade CD, Riva E, Recchia A. Prevalence of dementia in the

oldest old: the Monzino 80-plus population based study. Alzheimers Dement. 2015

Mar;11(3):258-70.e3. doi: 10.1016/j.jalz.2014.05.1750. Epub 2014 Aug 20. PubMed

PMID: 25150732.

134: Panza F, Solfrizzi V, Imbimbo BP, Giannini M, Santamato A, Seripa D,

Logroscino G. Efficacy and safety studies of gantenerumab in patients with

Alzheimer's disease. Expert Rev Neurother. 2014 Sep;14(9):973-86. doi:

10.1586/14737175.2014.945522. Epub 2014 Aug 1. Review. PubMed PMID: 25081412.

135: Panza F, Solfrizzi V, Imbimbo BP, Logroscino G. Amyloid-directed monoclonal

antibodies for the treatment of Alzheimer's disease: the point of no return?

Expert Opin Biol Ther. 2014 Oct;14(10):1465-76. doi:

10.1517/14712598.2014.935332. Epub 2014 Jun 30. Review. PubMed PMID: 24981190.

136: Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JB,

Dobson-Stone C, Brooks WS, Schofield PR, Halliday GM, Hodges JR, Piguet O,



Bartley L, Thompson E, Haan E, Hernández I, Ruiz A, Boada M, Borroni B, Padovani

A, Cruchaga C, Cairns NJ, Benussi L, Binetti G, Ghidoni R, Forloni G, Galimberti

D, Fenoglio C, Serpente M, Scarpini E, Clarimón J, Lleó A, Blesa R, Waldö ML,

Nilsson K, Nilsson C, Mackenzie IR, Hsiung GY, Mann DM, Grafman J, Morris CM,

Attems J, Griffiths TD, McKeith IG, Thomas AJ, Pietrini P, Huey ED, Wassermann

EM, Baborie A, Jaros E, Tierney MC, Pastor P, Razquin C, Ortega-Cubero S, Alonso

E, Perneczky R, Diehl-Schmid J, Alexopoulos P, Kurz A, Rainero I, Rubino E,

Pinessi L, Rogaeva E, St George-Hyslop P, Rossi G, Tagliavini F, Giaccone G, Rowe

JB, Schlachetzki JC, Uphill J, Collinge J, Mead S, Danek A, Van Deerlin VM,

Grossman M, Trojanowski JQ, van der Zee J, Deschamps W, Van Langenhove T, Cruts

M, Van Broeckhoven C, Cappa SF, Le Ber I, Hannequin D, Golfier V, Vercelletto M,

Brice A, Nacmias B, Sorbi S, Bagnoli S, Piaceri I, Nielsen JE, Hjermind LE,

Riemenschneider M, Mayhaus M, Ibach B, Gasparoni G, Pichler S, Gu W, Rossor MN,

Fox NC, Warren JD, Spillantini MG, Morris HR, Rizzu P, Heutink P, Snowden JS,

Rollinson S, Richardson A, Gerhard A, Bruni AC, Maletta R, Frangipane F, Cupidi

C, Bernardi L, Anfossi M, Gallo M, Conidi ME, Smirne N, Rademakers R, Baker M,

Dickson DW, Graff-Radford NR, Petersen RC, Knopman D, Josephs KA, Boeve BF,

Parisi JE, Seeley WW, Miller BL, Karydas AM, Rosen H, van Swieten JC, Dopper EG,

Seelaar H, Pijnenburg YA, Scheltens P, Logroscino G, Capozzo R, Novelli V, Puca

AA, Franceschi M, Postiglione A, Milan G, Sorrentino P, Kristiansen M, Chiang HH,

Graff C, Pasquier F, Rollin A, Deramecourt V, Lebert F, Kapogiannis D, Ferrucci

L, Pickering-Brown S, Singleton AB, Hardy J, Momeni P. Frontotemporal dementia

and its subtypes: a genome-wide association study. Lancet Neurol. 2014

Jul;13(7):686-99. doi: 10.1016/S1474-4422(14)70065-1. PubMed PMID: 24943344;


137: Santamato A, Micello MF, Panza F, Fortunato F, Picelli A, Smania N,

Logroscino G, Fiore P, Ranieri M. Adhesive taping vs. daily manual muscle

stretching and splinting after botulinum toxin type A injection for wrist and

fingers spastic overactivity in stroke patients: a randomized controlled trial.

Clin Rehabil. 2015 Jan;29(1):50-8. doi: 10.1177/0269215514537915. Epub 2014 Jun

10. PubMed PMID: 24917588.

138: Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC,

Biryukov S, Abbafati C, Abera SF, Abraham JP, Abu-Rmeileh NM, Achoki T,

AlBuhairan FS, Alemu ZA, Alfonso R, Ali MK, Ali R, Guzman NA, Ammar W, Anwari P,

Banerjee A, Barquera S, Basu S, Bennett DA, Bhutta Z, Blore J, Cabral N, Nonato

IC, Chang JC, Chowdhury R, Courville KJ, Criqui MH, Cundiff DK, Dabhadkar KC,

Dandona L, Davis A, Dayama A, Dharmaratne SD, Ding EL, Durrani AM, Esteghamati A,

Farzadfar F, Fay DF, Feigin VL, Flaxman A, Forouzanfar MH, Goto A, Green MA,

Gupta R, Hafezi-Nejad N, Hankey GJ, Harewood HC, Havmoeller R, Hay S, Hernandez

L, Husseini A, Idrisov BT, Ikeda N, Islami F, Jahangir E, Jassal SK, Jee SH,

Jeffreys M, Jonas JB, Kabagambe EK, Khalifa SE, Kengne AP, Khader YS, Khang YH,

Kim D, Kimokoti RW, Kinge JM, Kokubo Y, Kosen S, Kwan G, Lai T, Leinsalu M, Li Y,

Liang X, Liu S, Logroscino G, Lotufo PA, Lu Y, Ma J, Mainoo NK, Mensah GA,

Merriman TR, Mokdad AH, Moschandreas J, Naghavi M, Naheed A, Nand D, Narayan KM,

Nelson EL, Neuhouser ML, Nisar MI, Ohkubo T, Oti SO, Pedroza A, Prabhakaran D,

Roy N, Sampson U, Seo H, Sepanlou SG, Shibuya K, Shiri R, Shiue I, Singh GM,

Singh JA, Skirbekk V, Stapelberg NJ, Sturua L, Sykes BL, Tobias M, Tran BX,



Trasande L, Toyoshima H, van de Vijver S, Vasankari TJ, Veerman JL,

Velasquez-Melendez G, Vlassov VV, Vollset SE, Vos T, Wang C, Wang X, Weiderpass

E, Werdecker A, Wright JL, Yang YC, Yatsuya H, Yoon J, Yoon SJ, Zhao Y, Zhou M,

Zhu S, Lopez AD, Murray CJ, Gakidou E. Global, regional, and national prevalence

of overweight and obesity in children and adults during 1980-2013: a systematic

analysis for the Global Burden of Disease Study 2013. Lancet. 2014 Aug

30;384(9945):766-81. doi: 10.1016/S0140-6736(14)60460-8. Epub 2014 May 29.

Erratum in: Lancet. 2014 Aug 30;384(9945):746. PubMed PMID: 24880830; PubMed


139: Campana V, Milano G, Pagano E, Barba M, Cicione C, Salonna G, Lattanzi W,

Logroscino G. Bone substitutes in orthopaedic surgery: from basic science to

clinical practice. J Mater Sci Mater Med. 2014 Oct;25(10):2445-61. doi:

10.1007/s10856-014-5240-2. Epub 2014 May 28. Review. PubMed PMID: 24865980;


140: Wang H, Liddell CA, Coates MM, Mooney MD, Levitz CE, Schumacher AE, Apfel H,

Iannarone M, Phillips B, Lofgren KT, Sandar L, Dorrington RE, Rakovac I, Jacobs

TA, Liang X, Zhou M, Zhu J, Yang G, Wang Y, Liu S, Li Y, Ozgoren AA, Abera SF,

Abubakar I, Achoki T, Adelekan A, Ademi Z, Alemu ZA, Allen PJ, AlMazroa MA,

Alvarez E, Amankwaa AA, Amare AT, Ammar W, Anwari P, Cunningham SA, Asad MM,

Assadi R, Banerjee A, Basu S, Bedi N, Bekele T, Bell ML, Bhutta Z, Blore JD,

Basara BB, Boufous S, Breitborde N, Bruce NG, Bui LN, Carapetis JR, Cárdenas R,

Carpenter DO, Caso V, Castro RE, Catalá-Lopéz F, Cavlin A, Che X, Chiang PP,

Chowdhury R, Christophi CA, Chuang TW, Cirillo M, da Costa Leite I, Courville KJ,

Dandona L, Dandona R, Davis A, Dayama A, Deribe K, Dharmaratne SD, Dherani MK,

Dilmen U, Ding EL, Edmond KM, Ermakov SP, Farzadfar F, Fereshtehnejad SM, Fijabi

DO, Foigt N, Forouzanfar MH, Garcia AC, Geleijnse JM, Gessner BD, Goginashvili K,

Gona P, Goto A, Gouda HN, Green MA, Greenwell KF, Gugnani HC, Gupta R, Hamadeh

RR, Hammami M, Harb HL, Hay S, Hedayati MT, Hosgood HD, Hoy DG, Idrisov BT,

Islami F, Ismayilova S, Jha V, Jiang G, Jonas JB, Juel K, Kabagambe EK, Kazi DS,

Kengne AP, Kereselidze M, Khader YS, Khalifa SE, Khang YH, Kim D, Kinfu Y, Kinge

JM, Kokubo Y, Kosen S, Defo BK, Kumar GA, Kumar K, Kumar RB, Lai T, Lan Q,

Larsson A, Lee JT, Leinsalu M, Lim SS, Lipshultz SE, Logroscino G, Lotufo PA,

Lunevicius R, Lyons RA, Ma S, Mahdi AA, Marzan MB, Mashal MT, Mazorodze TT,

McGrath JJ, Memish ZA, Mendoza W, Mensah GA, Meretoja A, Miller TR, Mills EJ,

Mohammad KA, Mokdad AH, Monasta L, Montico M, Moore AR, Moschandreas J, Msemburi

WT, Mueller UO, Muszynska MM, Naghavi M, Naidoo KS, Narayan KM, Nejjari C, Ng M,

de Dieu Ngirabega J, Nieuwenhuijsen MJ, Nyakarahuka L, Ohkubo T, Omer SB, Caicedo

AJ, Pillay-van Wyk V, Pope D, Pourmalek F, Prabhakaran D, Rahman SU, Rana SM,

Reilly RQ, Rojas-Rueda D, Ronfani L, Rushton L, Saeedi MY, Salomon JA, Sampson U,

Santos IS, Sawhney M, Schmidt JC, Shakh-Nazarova M, She J, Sheikhbahaei S,

Shibuya K, Shin HH, Shishani K, Shiue I, Sigfusdottir ID, Singh JA, Skirbekk V,

Sliwa K, Soshnikov SS, Sposato LA, Stathopoulou VK, Stroumpoulis K, Tabb KM,

Talongwa RT, Teixeira CM, Terkawi AS, Thomson AJ, Thorne-Lyman AL, Toyoshima H,

Dimbuene ZT, Uwaliraye P, Uzun SB, Vasankari TJ, Vasconcelos AM, Vlassov VV,

Vollset SE, Waller S, Wan X, Weichenthal S, Weiderpass E, Weintraub RG, Westerman

R, Wilkinson JD, Williams HC, Yang YC, Yentur GK, Yip P, Yonemoto N, Younis M, Yu

C, Jin KY, El Sayed Zaki M, Zhu S, Vos T, Lopez AD, Murray CJ. Global, regional,



and national levels of neonatal, infant, and under-5 mortality during 1990-2013:

a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014

Sep 13;384(9947):957-79. doi: 10.1016/S0140-6736(14)60497-9. Epub 2014 May 2.

Erratum in: Lancet. 2014 Sep 13;384(9947):956. PubMed PMID: 24797572; PubMed


141: Tortelli R, Copetti M, Ruggieri M, Cortese R, Capozzo R, Leo A, D'Errico E,

Mastrapasqua M, Zoccolella S, Pellegrini F, Simone IL, Logroscino G.

Cerebrospinal fluid neurofilament light chain levels: marker of progression to

generalized amyotrophic lateral sclerosis. Eur J Neurol. 2015 Jan;22(1):215-8.

doi: 10.1111/ene.12421. Epub 2014 Apr 22. PubMed PMID: 24750431.

142: Siderowf A, Logroscino G. β-Amyloid in CSF: a window into Parkinson disease

dementia. Neurology. 2014 May 20;82(20):1758-9. doi:

10.1212/WNL.0000000000000437. Epub 2014 Apr 18. PubMed PMID: 24748673.

143: Santamato A, Micello MF, Panza F, Fortunato F, Logroscino G, Picelli A,

Manganotti P, Smania N, Fiore P, Ranieri M. Extracorporeal shock wave therapy for

the treatment of poststroke plantar-flexor muscles spasticity: a prospective

open-label study. Top Stroke Rehabil. 2014;21 Suppl 1:S17-24. doi:

10.1310/tsr21S1-S17. PubMed PMID: 24722040.

144: Pupillo E, Messina P, Giussani G, Logroscino G, Zoccolella S, Chiò A, Calvo

A, Corbo M, Lunetta C, Marin B, Mitchell D, Hardiman O, Rooney J, Stevic Z,

Bandettini di Poggio M, Filosto M, Cotelli MS, Perini M, Riva N, Tremolizzo L,

Vitelli E, Damiani D, Beghi E; EURALS Consortium. Physical activity and

amyotrophic lateral sclerosis: a European population-based case-control study.

Ann Neurol. 2014 May;75(5):708-16. doi: 10.1002/ana.24150. Epub 2014 May 21.


145: Johnson JO, Pioro EP, Boehringer A, Chia R, Feit H, Renton AE, Pliner HA,

Abramzon Y, Marangi G, Winborn BJ, Gibbs JR, Nalls MA, Morgan S, Shoai M, Hardy

J, Pittman A, Orrell RW, Malaspina A, Sidle KC, Fratta P, Harms MB, Baloh RH,

Pestronk A, Weihl CC, Rogaeva E, Zinman L, Drory VE, Borghero G, Mora G, Calvo A,

Rothstein JD; ITALSGEN, Drepper C, Sendtner M, Singleton AB, Taylor JP, Cookson

MR, Restagno G, Sabatelli M, Bowser R, Chiò A, Traynor BJ. Mutations in the

Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat Neurosci. 2014

May;17(5):664-666. doi: 10.1038/nn.3688. Epub 2014 Mar 30. PubMed PMID: 24686783;


146: Barba M, Cicione C, Bernardini C, Campana V, Pagano E, Michetti F,

Logroscino G, Lattanzi W. Spinal fusion in the next generation: gene and cell

therapy approaches. ScientificWorldJournal. 2014 Jan 28;2014:406159. doi:

10.1155/2014/406159. eCollection 2014. Review. PubMed PMID: 24672316; PubMed


147: Spalletta G, Caltagirone C, Padovani A, Sorbi S, Attar M, Colombo D,

Cravello L; E V O L U T I O N study Working Group. Cognitive and affective

changes in mild to moderate Alzheimer's disease patients undergoing switch of

cholinesterase inhibitors: a 6-month observational study. PLoS One. 2014 Feb

19;9(2):e89216. doi: 10.1371/journal.pone.0089216. eCollection 2014. PubMed PMID:


148: Panza F, Solfrizzi V, Imbimbo BP, Tortelli R, Santamato A, Logroscino G.

Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention



trials: the way forward. Expert Rev Clin Immunol. 2014 Mar;10(3):405-19. doi:

10.1586/1744666X.2014.883921. Epub 2014 Feb 4. Review. PubMed PMID: 24490853.

149: Panza F, Logroscino G, Imbimbo BP, Solfrizzi V. Is there still any hope for

amyloid-based immunotherapy for Alzheimer's disease? Curr Opin Psychiatry. 2014

Mar;27(2):128-37. doi: 10.1097/YCO.0000000000000041. Review. PubMed PMID:

24445401.

150: Pupillo E, Messina P, Logroscino G, Beghi E; SLALOM Group. Long-term

survival in amyotrophic lateral sclerosis: a population-based study. Ann Neurol.

2014 Feb;75(2):287-97. doi: 10.1002/ana.24096. Epub 2014 Feb 24. PubMed PMID:

24382602.

151: Quaranta N, Coppola F, Casulli M, Barulli MR, Panza F, Tortelli R, Capozzo

R, Leo A, Tursi M, Grasso A, Solfrizzi V, Sobbà C, Logroscino G. The prevalence

of peripheral and central hearing impairment and its relation to cognition in

older adults. Audiol Neurootol. 2014;19 Suppl 1:10-4. doi: 10.1159/000371597.

Epub 2015 Feb 20. Erratum in: Audiol Neurootol. 2015;20(2):135. Barulli, Orietta

[corrected to Barulli, Maria Rosa]; Lanza, Francesco [corrected to Panza,

Francesco]. PubMed PMID: 25733360.

152: Logroscino G, Bennett DA. Systematic reviews and meta-analyses in

neuroepidemiological research: applications and issues. Neuroepidemiology.

2014;42(1):5-6. doi: 10.1159/000355534. Epub 2013 Dec 12. PubMed PMID: 24356058.

153: Mezzapesa DM, D'Errico E, Tortelli R, Distaso E, Cortese R, Tursi M,

Federico F, Zoccolella S, Logroscino G, Dicuonzo F, Simone IL. Cortical thinning

and clinical heterogeneity in amyotrophic lateral sclerosis. PLoS One. 2013 Nov

20;8(11):e80748. doi: 10.1371/journal.pone.0080748. eCollection 2013. PubMed


154: Fogh I, Ratti A, Gellera C, Lin K, Tiloca C, Moskvina V, Corrado L, Sorarù

G, Cereda C, Corti S, Gentilini D, Calini D, Castellotti B, Mazzini L, Querin G,

Gagliardi S, Del Bo R, Conforti FL, Siciliano G, Inghilleri M, Saccà F,

Bongioanni P, Penco S, Corbo M, Sorbi S, Filosto M, Ferlini A, Di Blasio AM,

Signorini S, Shatunov A, Jones A, Shaw PJ, Morrison KE, Farmer AE, Van Damme P,

Robberecht W, Chiò A, Traynor BJ, Sendtner M, Melki J, Meininger V, Hardiman O,

Andersen PM, Leigh NP, Glass JD, Overste D, Diekstra FP, Veldink JH, van Es MA,

Shaw CE, Weale ME, Lewis CM, Williams J, Brown RH, Landers JE, Ticozzi N, Ceroni

M, Pegoraro E, Comi GP, D'Alfonso S, van den Berg LH, Taroni F, Al-Chalabi A,

Powell J, Silani V; SLAGEN Consortium and Collaborators. A genome-wide

association meta-analysis identifies a novel locus at 17q11.2 associated with

sporadic amyotrophic lateral sclerosis. Hum Mol Genet. 2014 Apr 15;23(8):2220-31.

doi: 10.1093/hmg/ddt587. Epub 2013 Nov 20. PubMed PMID: 24256812; PubMed Central

PMCID: PMC3959809.

155: dell'Aquila C, Zoccolella S, Cardinali V, de Mari M, Iliceto G, Tartaglione

B, Lamberti P, Logroscino G. Predictors of survival in a series of clinically

diagnosed progressive supranuclear palsy patients. Parkinsonism Relat Disord.

2013 Nov;19(11):980-5. doi: 10.1016/j.parkreldis.2013.06.014. Epub 2013 Aug 19.


156: Chiò A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, White

LA. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of

the published literature. Neuroepidemiology. 2013;41(2):118-30. doi:



10.1159/000351153. Epub 2013 Jul 11. Review. PubMed PMID: 23860588; PubMed


157: Chiò A, Battistini S, Calvo A, Caponnetto C, Conforti FL, Corbo M, Giannini

F, Mandrioli J, Mora G, Sabatelli M; ITALSGEN Consortium, Ajmone C, Mastro E,

Pain D, Mandich P, Penco S, Restagno G, Zollino M, Surbone A. Genetic counselling

in ALS: facts, uncertainties and clinical suggestions. J Neurol Neurosurg

Psychiatry. 2014 May;85(5):478-85. doi: 10.1136/jnnp-2013-305546. Epub 2013 Jul


158: Logroscino G. Amyotrophic lateral sclerosis descriptive studies: not only

rates and frequencies. Neuroepidemiology. 2013;41(1):62-3. doi:

10.1159/000350016. Epub 2013 May 25. PubMed PMID: 23711434.

159: Palmer SC, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A,

Pellegrini F, Saglimbene V, Logroscino G, Hedayati SS, Strippoli GF. Association

between depression and death in people with CKD: a meta-analysis of cohort

studies. Am J Kidney Dis. 2013 Sep;62(3):493-505. doi:

10.1053/j.ajkd.2013.02.369. Epub 2013 Apr 25. PubMed PMID: 23623139.

160: Galeotti F, Massari M, D'Alessandro R, Beghi E, Chiò A, Logroscino G,

Filippini G, Benedetti MD, Pugliatti M, Santuccio C, Raschetti R; ITANG study

group. Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination. Eur

J Epidemiol. 2013 May;28(5):433-44. doi: 10.1007/s10654-013-9797-8. Epub 2013 Mar


161: Palmer S, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A,

Pellegrini F, Saglimbene V, Logroscino G, Fishbane S, Strippoli GF. Prevalence of

depression in chronic kidney disease: systematic review and meta-analysis of

observational studies. Kidney Int. 2013 Jul;84(1):179-91. doi:

10.1038/ki.2013.77. Epub 2013 Mar 13. Review. PubMed PMID: 23486521.

162: Beghi E, Pupillo E, Bonito V, Buzzi P, Caponnetto C, Chiò A, Corbo M,

Giannini F, Inghilleri M, Bella VL, Logroscino G, Lorusso L, Lunetta C, Mazzini

L, Messina P, Mora G, Perini M, Quadrelli ML, Silani V, Simone IL, Tremolizzo L;

Italian ALS Study Group. Randomized double-blind placebo-controlled trial of

acetyl-L-carnitine for ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2013

Sep;14(5-6):397-405. doi: 10.3109/21678421.2013.764568. Epub 2013 Feb 19. PubMed

PMID: 23421600.

163: Aulisa AG, Guzzanti V, Galli M, Bottaro G, Vitelli O, Ferrara P, Logroscino

G. The familiarity of idiopathic scoliosis: statistical analysis and clinical

considerations. Eur J Orthop Surg Traumatol. 2013 Oct;23(7):781-4. doi:

10.1007/s00590-012-1060-6. Epub 2012 Aug 10. PubMed PMID: 23412192.

164: Pradas J, Puig T, Rojas-García R, Viguera ML, Gich I, Logroscino G; ALS-CAT

Group. Amyotrophic lateral sclerosis in Catalonia: a population based study.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14(4):278-83. doi:

10.3109/21678421.2012.749915. Epub 2013 Jan 4. PubMed PMID: 23286747.

165: Solfrizzi V, Scafato E, Frisardi V, Seripa D, Logroscino G, Maggi S, Imbimbo

BP, Galluzzo L, Baldereschi M, Gandin C, Di Carlo A, Inzitari D, Crepaldi G,

Pilotto A, Panza F; Italian Longitudinal Study on Aging Working Group. Frailty

syndrome and the risk of vascular dementia: the Italian Longitudinal Study on

Aging. Alzheimers Dement. 2013 Mar;9(2):113-22. doi: 10.1016/j.jalz.2011.09.223.

Epub 2012 Dec 12. PubMed PMID: 23245560.



166: Conforti FL, Spataro R, Sproviero W, Mazzei R, Cavalcanti F, Condino F,

Simone IL, Logroscino G, Patitucci A, Magariello A, Muglia M, Rodolico C,

Valentino P, Bono F, Colletti T, Monsurrò MR, Gambardella A, La Bella V. Ataxin-1

and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral

sclerosis. Neurology. 2012 Dec 11;79(24):2315-20. doi:

10.1212/WNL.0b013e318278b618. Epub 2012 Nov 28. PubMed PMID: 23197749.

167: Tortelli R, Conforti FL, Cortese R, D'Errico E, Distaso E, Mazzei R, Ungaro

C, Magariello A, Gambardella A, Logroscino G, Simone IL. Amyotrophic lateral

sclerosis: a new missense mutation in the SOD1 gene. Neurobiol Aging. 2013

Jun;34(6):1709.e3-5. doi: 10.1016/j.neurobiolaging.2012.10.027. Epub 2012 Nov 22.


168: Artuso L, Zoccolella S, Favia P, Amati A, Capozzo R, Logroscino G, Serlenga

L, Simone I, Gasparre G, Petruzzella V. Mitochondrial genome aberrations in

skeletal muscle of patients with motor neuron disease. Amyotroph Lateral Scler

Frontotemporal Degener. 2013 May;14(4):261-6. doi: 10.3109/21678421.2012.735239.

Epub 2012 Oct 24. PubMed PMID: 23134511.

169: Barba M, Pirozzi F, Saulnier N, Vitali T, Natale MT, Logroscino G, Robbins

PD, Gambotto A, Neri G, Michetti F, Pola E, Lattanzi W. Lim mineralization

protein 3 induces the osteogenic differentiation of human amniotic fluid stromal

cells through Kruppel-like factor-4 downregulation and further bone-specific gene

expression. J Biomed Biotechnol. 2012;2012:813894. doi: 10.1155/2012/813894. Epub

2012 Oct 2. PubMed PMID: 23097599; PubMed Central PMCID: PMC3471036.

170: Ciriello V, Maccauro G, Ziranu A, Saccornanno M, Pagano E, Logroscino G.

Collatamp sponges in the management of open fractures. Acta Biomed. 2012

Apr;83(1):62-8. PubMed PMID: 22978061.

171: Santamato A, Panza F, Ranieri M, Frisardi V, Micello MF, Filoni S, Fortunato

F, Intiso D, Basciani M, Logroscino G, Fiore P. Efficacy and safety of higher

doses of botulinum toxin type A NT 201 free from complexing proteins in the upper

and lower limb spasticity after stroke. J Neural Transm (Vienna). 2013

Mar;120(3):469-76. doi: 10.1007/s00702-012-0892-x. Epub 2012 Sep 7. PubMed PMID:

22955957.

172: Zoccolella S, Artuso L, Capozzo R, Amati A, Guerra F, Simone I, Logroscino

G, Petruzzella V. Mitochondrial genome large rearrangements in the skeletal

muscle of a patient with PMA. Eur J Neurol. 2012 Jul;19(7):e63-4. doi:

10.1111/j.1468-1331.2012.03720.x. PubMed PMID: 22691093.

173: Tortelli R, Ruggieri M, Cortese R, D'Errico E, Capozzo R, Leo A,

Mastrapasqua M, Zoccolella S, Leante R, Livrea P, Logroscino G, Simone IL.

Elevated cerebrospinal fluid neurofilament light levels in patients with

amyotrophic lateral sclerosis: a possible marker of disease severity and

progression. Eur J Neurol. 2012 Dec;19(12):1561-7. doi:

10.1111/j.1468-1331.2012.03777.x. Epub 2012 Jun 11. PubMed PMID: 22680408.

174: Migliore A, Bella A, Bisignani M, Calderaro M, De Amicis D, Logroscino G,

Mariottini F, Moreschini O, Massafra U, Bizzi E, Laganà B, Piscitelli P, Tormenta

S. Total hip replacement rate in a cohort of patients affected by symptomatic hip

osteoarthritis following intra-articular sodium hyaluronate (MW 1,500-2,000 kDa)

ORTOBRIX study. Clin Rheumatol. 2012 Aug;31(8):1187-96. doi:

10.1007/s10067-012-1994-4. Epub 2012 Jun 8. PubMed PMID: 22678146.



175: Pierucci P, Lenato GM, Suppressa P, Lastella P, Triggiani V, Valerio R,

Comelli M, Salvante D, Stella A, Resta N, Logroscino G, Resta F, Sabbà C. A long

diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: a

questionnaire-based retrospective study. Orphanet J Rare Dis. 2012 Jun 7;7:33.


176: Panza F, Solfrizzi V, Logroscino G, Maggi S, Santamato A, Seripa D, Pilotto

A. Current epidemiological approaches to the metabolic-cognitive syndrome. J

Alzheimers Dis. 2012;30 Suppl 2:S31-75. doi: 10.3233/JAD-2012-111496. Review.


177: Pupillo E, Messina P, Logroscino G, Zoccolella S, Chiò A, Calvo A, Corbo M,

Lunetta C, Micheli A, Millul A, Vitelli E, Beghi E; EURALS Consortium. Trauma and

amyotrophic lateral sclerosis: a case-control study from a population-based

registry. Eur J Neurol. 2012 Dec;19(12):1509-17. doi:

10.1111/j.1468-1331.2012.03723.x. Epub 2012 Apr 27. PubMed PMID: 22537412.

178: Logroscino G, Malerba G, Pagano E, Ziranu A, Ciriello V. The use of

collatamp in total hip arthroplasty. Acta Biomed. 2011 Aug;82(2):154-9. PubMed

PMID: 22480071.

179: Sabatelli M, Conforti FL, Zollino M, Mora G, Monsurrò MR, Volanti P, Marinou

K, Salvi F, Corbo M, Giannini F, Battistini S, Penco S, Lunetta C, Quattrone A,

Gambardella A, Logroscino G, Simone I, Bartolomei I, Pisano F, Tedeschi G, Conte

A, Spataro R, La Bella V, Caponnetto C, Mancardi G, Mandich P, Sola P, Mandrioli

J, Renton AE, Majounie E, Abramzon Y, Marrosu F, Marrosu MG, Murru MR, Sotgiu MA,

Pugliatti M, Rodolico C; ITALSGEN Consortium, Moglia C, Calvo A, Ossola I,

Brunetti M, Traynor BJ, Borghero G, Restagno G, Chiò A. C9ORF72 hexanucleotide

repeat expansions in the Italian sporadic ALS population. Neurobiol Aging. 2012

Aug;33(8):1848.e15-20. doi: 10.1016/j.neurobiolaging.2012.02.011. Epub 2012 Mar


180: Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, Chiò A,

Restagno G, Nicolaou N, Simon-Sanchez J, van Swieten JC, Abramzon Y, Johnson JO,

Sendtner M, Pamphlett R, Orrell RW, Mead S, Sidle KC, Houlden H, Rohrer JD,

Morrison KE, Pall H, Talbot K, Ansorge O; Chromosome 9-ALS/FTD Consortium; French

research network on FTLD/FTLD/ALS; ITALSGEN Consortium, Hernandez DG, Arepalli S,

Sabatelli M, Mora G, Corbo M, Giannini F, Calvo A, Englund E, Borghero G, Floris

GL, Remes AM, Laaksovirta H, McCluskey L, Trojanowski JQ, Van Deerlin VM,

Schellenberg GD, Nalls MA, Drory VE, Lu CS, Yeh TH, Ishiura H, Takahashi Y, Tsuji

S, Le Ber I, Brice A, Drepper C, Williams N, Kirby J, Shaw P, Hardy J, Tienari

PJ, Heutink P, Morris HR, Pickering-Brown S, Traynor BJ. Frequency of the C9orf72

hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis

and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012

Apr;11(4):323-30. doi: 10.1016/S1474-4422(12)70043-1. Epub 2012 Mar 9. PubMed


181: Panza F, Frisardi V, Seripa D, Logroscino G, Santamato A, Imbimbo BP,

Scafato E, Pilotto A, Solfrizzi V. Alcohol consumption in mild cognitive

impairment and dementia: harmful or neuroprotective? Int J Geriatr Psychiatry.

2012 Dec;27(12):1218-38. doi: 10.1002/gps.3772. Epub 2012 Mar 7. Review. PubMed

PMID: 22396249.

182: Chiò A, Borghero G, Restagno G, Mora G, Drepper C, Traynor BJ, Sendtner M,



Brunetti M, Ossola I, Calvo A, Pugliatti M, Sotgiu MA, Murru MR, Marrosu MG,

Marrosu F, Marinou K, Mandrioli J, Sola P, Caponnetto C, Mancardi G, Mandich P,

La Bella V, Spataro R, Conte A, Monsurrò MR, Tedeschi G, Pisano F, Bartolomei I,

Salvi F, Lauria Pinter G, Simone I, Logroscino G, Gambardella A, Quattrone A,

Lunetta C, Volanti P, Zollino M, Penco S, Battistini S; ITALSGEN consortium,

Renton AE, Majounie E, Abramzon Y, Conforti FL, Giannini F, Corbo M, Sabatelli M.

Clinical characteristics of patients with familial amyotrophic lateral sclerosis

carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain.

2012 Mar;135(Pt 3):784-93. doi: 10.1093/brain/awr366. PubMed PMID: 22366794;


183: Cassidy A, Rimm EB, O'Reilly EJ, Logroscino G, Kay C, Chiuve SE, Rexrode KM.

Dietary flavonoids and risk of stroke in women. Stroke. 2012 Apr;43(4):946-51.

doi: 10.1161/STROKEAHA.111.637835. Epub 2012 Feb 23. PubMed PMID: 22363060;


184: Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A,

Greco A, Seripa D, Pilotto A. Immunotherapy for Alzheimer's disease: from

anti-β-amyloid to tau-based immunization strategies. Immunotherapy. 2012

Feb;4(2):213-38. doi: 10.2217/imt.11.170. Review. PubMed PMID: 22339463.

185: Solfrizzi V, Scafato E, Frisardi V, Seripa D, Logroscino G, Kehoe PG,

Imbimbo BP, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari

D, Maggi S, Pilotto A, Panza F; Italian Longitudinal Study on Aging Working

Group. Angiotensin-converting enzyme inhibitors and incidence of mild cognitive

impairment. The Italian Longitudinal Study on Aging. Age (Dordr). 2013

Apr;35(2):441-53. doi: 10.1007/s11357-011-9360-z. Epub 2011 Dec 28. PubMed PMID:


186: Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A,

Greco A, Seripa D, Pilotto A. Interacting with γ-secretase for treating

Alzheimer's disease: from inhibition to modulation. Curr Med Chem.

2011;18(35):5430-47. Review. PubMed PMID: 22087836.

187: Sproviero W, La Bella V, Mazzei R, Valentino P, Rodolico C, Simone IL,

Logroscino G, Ungaro C, Magariello A, Patitucci A, Tedeschi G, Spataro R, Condino

F, Bono F, Citrigno L, Monsurrò MR, Muglia M, Gambardella A, Quattrone A,

Conforti FL. FUS mutations in sporadic amyotrophic lateral sclerosis: clinical

and genetic analysis. Neurobiol Aging. 2012 Apr;33(4):837.e1-5. doi:

10.1016/j.neurobiolaging.2011.10.005. Epub 2011 Nov 4. PubMed PMID: 22055719.

188: Thurman DJ, Beghi E, Begley CE, Berg AT, Buchhalter JR, Ding D, Hesdorffer

DC, Hauser WA, Kazis L, Kobau R, Kroner B, Labiner D, Liow K, Logroscino G,

Medina MT, Newton CR, Parko K, Paschal A, Preux PM, Sander JW, Selassie A,

Theodore W, Tomson T, Wiebe S; ILAE Commission on Epidemiology. Standards for

epidemiologic studies and surveillance of epilepsy. Epilepsia. 2011 Sep;52 Suppl

7:2-26. doi: 10.1111/j.1528-1167.2011.03121.x. PubMed PMID: 21899536.

189: Simone IL, Ruggieri M, Tortelli R, Ceci E, D'Errico E, Leo A, Zoccolella S,

Mastrapasqua M, Capozzo R, Livrea P, Logroscino G. Serum N-acetylaspartate level

in amyotrophic lateral sclerosis. Arch Neurol. 2011 Oct;68(10):1308-12. doi:

10.1001/archneurol.2011.217. PubMed PMID: 21987545.

190: Pola E, Nasto LA, Tampieri A, Lattanzi W, Di Giacomo G, Colangelo D,

Ciriello V, Pagano E, Spinelli S, Robbins PD, Logroscino G. Bioplasty for



vertebral fractures: preliminary results of a pre-clinical study on goats using

autologous modified skin fibroblasts. Int J Immunopathol Pharmacol. 2011

Jan-Mar;24(1 Suppl 2):139-42. PubMed PMID: 21669153; PubMed Central PMCID:

PMC3512194.

191: Logroscino G, Ciriello V, D'Antonio E, De Tullio V, Piciocco P,

Magliocchetti Lombi G, Santori FS, Albanese CV. Bone integration of new stemless

hip implants (proxima vs. nanos). A DXA study: preliminary results. Int J

Immunopathol Pharmacol. 2011 Jan-Mar;24(1 Suppl 2):113-6. PubMed PMID: 21669148.

192: Beghi E, Pupillo E, Messina P, Giussani G, Chiò A, Zoccolella S, Moglia C,

Corbo M, Logroscino G; EURALS Group. Coffee and amyotrophic lateral sclerosis: a

possible preventive role. Am J Epidemiol. 2011 Nov 1;174(9):1002-8. doi:

10.1093/aje/kwr229. Epub 2011 Sep 26. PubMed PMID: 21946385.

193: Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR,

Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A,

Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW,

Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW,

Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K,

Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D,

Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kaivorinne AL,

Hölttä-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chiò A, Restagno G,

Borghero G, Sabatelli M; ITALSGEN Consortium, Heckerman D, Rogaeva E, Zinman L,

Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD,

Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S,

Morris HR, Tienari PJ, Traynor BJ. A hexanucleotide repeat expansion in C9ORF72

is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011 Oct 20;72(2):257-68.

doi: 10.1016/j.neuron.2011.09.010. Epub 2011 Sep 21. PubMed PMID: 21944779;


194: Pan A, Okereke OI, Sun Q, Logroscino G, Manson JE, Willett WC, Ascherio A,

Hu FB, Rexrode KM. Depression and incident stroke in women. Stroke. 2011

Oct;42(10):2770-5. doi: 10.1161/STROKEAHA.111.617043. Epub 2011 Aug 11. PubMed


195: Panza F, Frisardi V, Seripa D, D'Onofrio G, Santamato A, Masullo C,

Logroscino G, Solfrizzi V, Pilotto A. Apolipoprotein E genotypes and

neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. Ageing

Res Rev. 2012 Jan;11(1):87-103. doi: 10.1016/j.arr.2011.06.005. Epub 2011 Jul 7.


196: Lucca U, Garrì M, Recchia A, Logroscino G, Tiraboschi P, Franceschi M,

Bertinotti C, Biotti A, Gargantini E, Maragna M, Nobili A, Pasina L, Franchi C,

Riva E, Tettamanti M. A Population-based study of dementia in the oldest old: the

Monzino 80-plus study. BMC Neurol. 2011 May 25;11:54. doi:

10.1186/1471-2377-11-54. PubMed PMID: 21612585; PubMed Central PMCID: PMC3120664.

197: Solfrizzi V, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, D'Onofrio G,

Addante F, Sancarlo D, Cascavilla L, Pilotto A, Panza F. Mediterranean diet in

predementia and dementia syndromes. Curr Alzheimer Res. 2011 Aug;8(5):520-42.


198: Panza F, Frisardi V, Imbimbo BP, Seripa D, Paris F, Santamato A, D'Onofrio

G, Logroscino G, Pilotto A, Solfrizzi V. Anti-β-amyloid immunotherapy for



Alzheimer's disease: focus on bapineuzumab. Curr Alzheimer Res. 2011

Dec;8(8):808-17. Review. PubMed PMID: 21592055.

199: Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP,

Pilotto A. Diet and Alzheimer's disease risk factors or prevention: the current

evidence. Expert Rev Neurother. 2011 May;11(5):677-708. doi: 10.1586/ern.11.56.


200: Solfrizzi V, Scafato E, Frisardi V, Sancarlo D, Seripa D, Logroscino G,

Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S,

Pilotto A, Panza F; Italian Longitudinal Study on Aging Working Group. Frailty

syndrome and all-cause mortality in demented patients: the Italian Longitudinal

Study on Aging. Age (Dordr). 2012 Apr;34(2):507-17. doi:

10.1007/s11357-011-9247-z. Epub 2011 Apr 26. PubMed PMID: 21519879; PubMed


201: Wang H, O'Reilly ÉJ, Weisskopf MG, Logroscino G, McCullough ML, Schatzkin A,

Kolonel LN, Ascherio A. Vitamin E intake and risk of amyotrophic lateral

sclerosis: a pooled analysis of data from 5 prospective cohort studies. Am J

Epidemiol. 2011 Mar 15;173(6):595-602. doi: 10.1093/aje/kwq416. Epub 2011 Feb 18.


202: Wang H, O'Reilly ÉJ, Weisskopf MG, Logroscino G, McCullough ML, Thun MJ,

Schatzkin A, Kolonel LN, Ascherio A. Smoking and risk of amyotrophic lateral

sclerosis: a pooled analysis of 5 prospective cohorts. Arch Neurol. 2011

Feb;68(2):207-13. doi: 10.1001/archneurol.2010.367. PubMed PMID: 21320987; PubMed


203: Papazacharias A, Logroscino G, Barulli MR, Nardini M. Late life depression

and late onset depression: are the same clinical and pathopsysiological picture?

Psychiatr Danub. 2010 Nov;22 Suppl 1:S108-10. PubMed PMID: 21057414.

204: Driver JA, Logroscino G, Lu L, Gaziano JM, Kurth T. Use of non-steroidal

anti-inflammatory drugs and risk of Parkinson's disease: nested case-control

study. BMJ. 2011 Jan 20;342:d198. doi: 10.1136/bmj.d198. PubMed PMID: 21252104;


205: Imbimbo BP, Panza F, Frisardi V, Solfrizzi V, D'Onofrio G, Logroscino G,

Seripa D, Pilotto A. Therapeutic intervention for Alzheimer's disease with

γ-secretase inhibitors: still a viable option? Expert Opin Investig Drugs. 2011

Mar;20(3):325-41. doi: 10.1517/13543784.2011.550572. Epub 2011 Jan 11. Review.


206: Hesdorffer DC, Logroscino G, Benn EK, Katri N, Cascino G, Hauser WA.

Estimating risk for developing epilepsy: a population-based study in Rochester,

Minnesota. Neurology. 2011 Jan 4;76(1):23-7. doi: 10.1212/WNL.0b013e318204a36a.


207: Marin B, Couratier P, Preux PM, Logroscino G. Can mortality data be used to

estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology.

2011;36(1):29-38. doi: 10.1159/000321930. Epub 2010 Nov 17. Review. PubMed PMID:

21088432.

208: Logroscino G, Kurth T. Ischemic stroke: coffee may pull the trigger.

Neurology. 2010 Nov 2;75(18):1576-7. doi: 10.1212/WNL.0b013e3181fb4513. Epub 2010

Sep 29. PubMed PMID: 20881274.

209: Zoccolella S, Simone IL, Capozzo R, Tortelli R, Leo A, D'Errico E,



Logroscino G. An exploratory study of serum urate levels in patients with

amyotrophic lateral sclerosis. J Neurol. 2011 Feb;258(2):238-43. doi:

10.1007/s00415-010-5735-9. Epub 2010 Sep 15. PubMed PMID: 20842370.

210: Chiò A, Borghero G, Calvo A, Capasso M, Caponnetto C, Corbo M, Giannini F,

Logroscino G, Mandrioli J, Marcello N, Mazzini L, Moglia C, Monsurrò MR, Mora G,

Patti F, Perini M, Pietrini V, Pisano F, Pupillo E, Sabatelli M, Salvi F, Silani

V, Simone IL, Sorarù G, Tola MR, Volanti P, Beghi E; LITALS Study Group. Lithium

carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding

trial. Neurology. 2010 Aug 17;75(7):619-25. doi: 10.1212/WNL.0b013e3181ed9e7c.

Epub 2010 Aug 11. PubMed PMID: 20702794.

211: Beghi E, Chiò A, Couratier P, Esteban J, Hardiman O, Logroscino G, Millul A,

Mitchell D, Preux PM, Pupillo E, Stevic Z, Swingler R, Traynor BJ, Van den Berg

LH, Veldink JH, Zoccolella S; Eurals Consortium. The epidemiology and treatment

of ALS: focus on the heterogeneity of the disease and critical appraisal of

therapeutic trials. Amyotroph Lateral Scler. 2011 Jan;12(1):1-10. doi:

10.3109/17482968.2010.502940. Epub 2010 Aug 11. Review. PubMed PMID: 20698807;


212: Kurth T, Logroscino G. Can dementia be prevented? BMJ. 2010 Aug 5;341:c4201.

doi: 10.1136/bmj.c4201. PubMed PMID: 20688836.

213: Zoccolella S, Lamberti SV, Iliceto G, Santamato A, Lamberti P, Logroscino G.

Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease:

potential implications in cognitive dysfunction and dementia? Curr Med Chem.

2010;17(28):3253-61. Review. PubMed PMID: 20666719.

214: Alonso A, Logroscino G, Hernán MA. Smoking and the risk of amyotrophic

lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg

Psychiatry. 2010 Nov;81(11):1249-52. doi: 10.1136/jnnp.2009.180232. Epub 2010 Jul


215: Zoccolella S, Savarese M, Lamberti P, Manni R, Pacchetti C, Logroscino G.

Sleep disorders and the natural history of Parkinson's disease: the contribution

of epidemiological studies. Sleep Med Rev. 2011 Feb;15(1):41-50. doi:

10.1016/j.smrv.2010.02.004. Epub 2010 Jul 15. Review. PubMed PMID: 20634113.

216: Panza F, Frisardi V, Imbimbo BP, Capurso C, Logroscino G, Sancarlo D, Seripa

D, Vendemiale G, Pilotto A, Solfrizzi V. REVIEW: γ-Secretase inhibitors for the

treatment of Alzheimer's disease: The current state. CNS Neurosci Ther. 2010

Oct;16(5):272-84. doi: 10.1111/j.1755-5949.2010.00164.x. Epub 2010 Jun 16.


217: Beghi E, Logroscino G, Chiò A, Hardiman O, Millul A, Mitchell D, Swingler R,

Traynor BJ. Amyotrophic lateral sclerosis, physical exercise, trauma and sports:

results of a population-based pilot case-control study. Amyotroph Lateral Scler.

2010 May 3;11(3):289-92. doi: 10.3109/17482960903384283. PubMed PMID: 20433412;


218: Rossetti AO, Oddo M, Logroscino G, Kaplan PW. Prognostication after cardiac

arrest and hypothermia: a prospective study. Ann Neurol. 2010 Mar;67(3):301-7.

doi: 10.1002/ana.21984. PubMed PMID: 20373341.

219: Manobianca G, Zoccolella S, Petruzzellis A, Miccoli A, Logroscino G. The

incidence of major stroke subtypes in southern Italy: a population-based study.

Eur J Neurol. 2010 Sep;17(9):1148-55. doi: 10.1111/j.1468-1331.2010.02983.x. Epub



2010 Mar 11. PubMed PMID: 20298424.

220: Zoccolella S, dell'Aquila C, Specchio LM, Logroscino G, Lamberti P. Elevated

homocysteine levels in Parkinson's Disease: is there anything besides L-dopa

treatment? Curr Med Chem. 2010;17(3):213-21. Review. PubMed PMID: 20214564.

221: Alonso A, Logroscino G, Jick SS, Hernán MA. Association of smoking with

amyotrophic lateral sclerosis risk and survival in men and women: a prospective

study. BMC Neurol. 2010 Jan 14;10:6. doi: 10.1186/1471-2377-10-6. PubMed PMID:


222: Sorarù G, Ermani M, Logroscino G, Palmieri A, D' Ascenzo C, Orsetti V, Volpe

M, Cima V, Zara G, Pegoraro E, Angelini C. Natural history of upper motor

neuron-dominant ALS. Amyotroph Lateral Scler. 2010 Oct;11(5):424-9. doi:

10.3109/17482960903300867. PubMed PMID: 19929748.

223: Rossetti AO, Novy J, Ruffieux C, Olivier P, Foletti GB, Hayoz D, Burnand B,

Logroscino G. Management and prognosis of status epilepticus according to

hospital setting: a prospective study. Swiss Med Wkly. 2009 Dec

12;139(49-50):719-23. doi: smw-12805. PubMed PMID: 19924584.

224: Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, Traynor

BG; Eurals Consortium. Prognostic factors in ALS: A critical review. Amyotroph

Lateral Scler. 2009 Oct-Dec;10(5-6):310-23. doi: 10.3109/17482960802566824.


225: Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a

prospective observational study. Epilepsia. 2010 Feb;51(2):251-6. doi:

10.1111/j.1528-1167.2009.02323.x. Epub 2009 Oct 8. PubMed PMID: 19817823.

226: Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ,

Millul A, Benn E, Beghi E; EURALS. Incidence of amyotrophic lateral sclerosis in

Europe. J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):385-90. doi:

10.1136/jnnp.2009.183525. Epub 2009 Aug 25. PubMed PMID: 19710046; PubMed Central

PMCID: PMC2850819.

227: Papantonio AM, Beghi E, Fogli D, Zarrelli M, Logroscino G, Bentivoglio A,

Simone P, Tonali P, Specchio LM. Prevalence of primary focal or segmental

dystonia in adults in the district of foggia, southern Italy: a service-based

study. Neuroepidemiology. 2009;33(2):117-23. doi: 10.1159/000226124. Epub 2009

Jun 26. PubMed PMID: 19556806.

228: Kurth T, Schürks M, Logroscino G, Buring JE. Migraine frequency and risk of

cardiovascular disease in women. Neurology. 2009 Aug 25;73(8):581-8. doi:

10.1212/WNL.0b013e3181ab2c20. Epub 2009 Jun 24. PubMed PMID: 19553594; PubMed


229: Zoccolella S, Bendotti C, Beghi E, Logroscino G. Homocysteine levels and

amyotrophic lateral sclerosis: A possible link. Amyotroph Lateral Scler.

2010;11(1-2):140-7. doi: 10.3109/17482960902919360. Review. PubMed PMID:

19551535.

230: Alonso A, Logroscino G, Jick SS, Hernán MA. Incidence and lifetime risk of

motor neuron disease in the United Kingdom: a population-based study. Eur J

Neurol. 2009 Jun;16(6):745-51. PubMed PMID: 19475756; PubMed Central PMCID:

PMC3093130.

231: Cima V, Logroscino G, D'Ascenzo C, Palmieri A, Volpe M, Briani C, Pegoraro

E, Angelini C, Soraru G. Epidemiology of ALS in Padova district, Italy, from 1992



to 2005. Eur J Neurol. 2009 Aug;16(8):920-4. doi:

10.1111/j.1468-1331.2009.02623.x. Epub 2009 Mar 31. PubMed PMID: 19473365.

232: Buratti CA, D'Arrigo C, Guido G, Lenzi F, Logroscino GD, Magliocchetti G,

Mannocci C, Patella S, Patella V, Salvi V, Speranza A, Speciale D, Spinarelli A,

Topa D. Assessment of the initial stability of the Symax femoral stem with

EBRA-FCA: a multicentric study of 85 cases. Hip Int. 2009 Jan-Mar;19(1):24-9.


233: Alonso A, Rodríguez LA, Logroscino G, Hernán MA. Use of antidepressants and

the risk of Parkinson's disease: a prospective study. J Neurol Neurosurg

Psychiatry. 2009 Jun;80(6):671-4. doi: 10.1136/jnnp.2008.152983. PubMed PMID:


234: Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O.

Reduced frequency of ALS in an ethnically mixed population: a population-based

mortality study. Neurology. 2009 May 12;72(19):1640-5. doi:

10.1212/WNL.0b013e3181a55f7b. PubMed PMID: 19433736.

235: Zoccolella S, dell'Aquila C, Abruzzese G, Antonini A, Bonuccelli U, Canesi

M, Cristina S, Marchese R, Pacchetti C, Zagaglia R, Logroscino G, Defazio G,

Lamberti P, Livrea P. Hyperhomocysteinemia in levodopa-treated patients with

Parkinson's disease dementia. Mov Disord. 2009 May 15;24(7):1028-33. doi:

10.1002/mds.22511. PubMed PMID: 19353704.

236: Logroscino G. Status Epilepticus: different venues, different resources, but

similar prognosis. Eur J Neurol. 2009 Apr;16(4):436-7. doi:

10.1111/j.1468-1331.2008.02402.x. PubMed PMID: 19348618.

237: Beghi E, Pupillo E, Zoccolella S; European Amyotrophic Lateral Sclerosis

Consortium (EURALS). 148th ENMC international workshop on the scientific

contributions of the EURALS consortium on amyotrophic lateral sclerosis.

Neuromuscul Disord. 2009 May;19(5):379-81. doi: 10.1016/j.nmd.2009.02.008. Epub

2009 Apr 3. PubMed PMID: 19345585.

238: Lopez-Garcia E, Rodriguez-Artalejo F, Rexrode KM, Logroscino G, Hu FB, van

Dam RM. Coffee consumption and risk of stroke in women. Circulation. 2009 Mar

3;119(8):1116-23. doi: 10.1161/CIRCULATIONAHA.108.826164. Epub 2009 Feb 16.


239: Driver JA, Logroscino G, Gaziano JM, Kurth T. Incidence and remaining

lifetime risk of Parkinson disease in advanced age. Neurology. 2009 Feb

3;72(5):432-8. doi: 10.1212/01.wnl.0000341769.50075.bb. PubMed PMID: 19188574;


240: Bronstein J, Carvey P, Chen H, Cory-Slechta D, DiMonte D, Duda J, English P,

Goldman S, Grate S, Hansen J, Hoppin J, Jewell S, Kamel F, Koroshetz W, Langston

JW, Logroscino G, Nelson L, Ravina B, Rocca W, Ross GW, Schettler T,

Schwarzschild M, Scott B, Seegal R, Singleton A, Steenland K, Tanner CM, Van Den

Eeden S, Weisskopf M. Meeting report: consensus statement-Parkinson's disease and

the environment: collaborative on health and the environment and Parkinson's

Action Network (CHE PAN) conference 26-28 June 2007. Environ Health Perspect.

2009 Jan;117(1):117-21. doi: 10.1289/ehp.11702. Epub 2008 Aug 26. PubMed PMID:


241: Sanz P, Nogué S, Vilchez D, Salvadó E, Casal A, Logroscino G. Myoclonic

encephalopathy after exposure to trichloroethylene. Ind Health. 2008



Dec;46(6):635-7. PubMed PMID: 19088417.

242: Driver JA, Djoussé L, Logroscino G, Gaziano JM, Kurth T. Incidence of

cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ.

2008 Dec 9;337:a2467. doi: 10.1136/bmj.a2467. PubMed PMID: 19066258; PubMed


243: Ferrara PE, Rabini A, Maggi L, Piazzini DB, Logroscino G, Magliocchetti G,

Amabile E, Tancredi G, Aulisa AG, Padua L, Aprile I, Bertolini C. Effect of

pre-operative physiotherapy in patients with end-stage osteoarthritis undergoing

hip arthroplasty. Clin Rehabil. 2008 Oct-Nov;22(10-11):977-86. doi:

10.1177/0269215508094714. Erratum in: Clin Rehabil. 2008 Dec;22(12):1137. Lombi,

G Magliocchetti [corrected to Magliocchetti, G]. PubMed PMID: 18955429.

244: Logroscino G, Gao X, Chen H, Wing A, Ascherio A. Dietary iron intake and

risk of Parkinson's disease. Am J Epidemiol. 2008 Dec 15;168(12):1381-8. doi:

10.1093/aje/kwn273. Epub 2008 Oct 21. PubMed PMID: 18945687; PubMed Central

PMCID: PMC2727188.

245: Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield

EB. Status Epilepticus Severity Score (STESS): a tool to orient early treatment

strategy. J Neurol. 2008 Oct;255(10):1561-6. doi: 10.1007/s00415-008-0989-1. Epub

2008 Sep 3. PubMed PMID: 18769858.

246: Manobianca G, Zoccolella S, Petruzzellis A, Miccoli A, Logroscino G. Low

incidence of stroke in southern Italy: a population-based study. Stroke. 2008

Nov;39(11):2923-8. doi: 10.1161/STROKEAHA.108.519421. Epub 2008 Aug 14. PubMed

PMID: 18703805.

247: Chiuve SE, Rexrode KM, Spiegelman D, Logroscino G, Manson JE, Rimm EB.

Primary prevention of stroke by healthy lifestyle. Circulation. 2008 Aug

26;118(9):947-54. doi: 10.1161/CIRCULATIONAHA.108.781062. Epub 2008 Aug 12.


248: Kurth T, Schürks M, Logroscino G, Gaziano JM, Buring JE. Migraine, vascular

risk, and cardiovascular events in women: prospective cohort study. BMJ. 2008 Aug

7;337:a636. doi: 10.1136/bmj.a636. PubMed PMID: 18687721; PubMed Central PMCID:

PMC2505092.

249: Lattanzi W, Parrilla C, Fetoni A, Logroscino G, Straface G, Pecorini G,

Stigliano E, Tampieri A, Bedini R, Pecci R, Michetti F, Gambotto A, Robbins PD,

Pola E. Ex vivo-transduced autologous skin fibroblasts expressing human Lim

mineralization protein-3 efficiently form new bone in animal models. Gene Ther.

2008 Oct;15(19):1330-43. doi: 10.1038/gt.2008.116. Epub 2008 Jul 17. PubMed PMID:


250: Driver JA, Smith A, Buring JE, Gaziano JM, Kurth T, Logroscino G.

Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease.

Diabetes Care. 2008 Oct;31(10):2003-5. doi: 10.2337/dc08-0688. Epub 2008 Jul 3.


251: Beghi E, Millul A, Logroscino G, Vitelli E, Micheli A; SLALOM GROUP. Outcome

measures and prognostic indicators in patients with amyotrophic lateral

sclerosis. Amyotroph Lateral Scler. 2008 Jun;9(3):163-7. doi:

10.1080/17482960801942695. PubMed PMID: 18574760.

252: Rossetti AO, Logroscino G. Re: In-hospital mortality of generalized

convulsive status epilepticus: a large US sample. Neurology. 2008 May



13;70(20):1939; author reply 1939-40. doi: 10.1212/01.wnl.0000314640.81907.a0.


253: Maccauro G, Liuzza F, Scaramuzzo L, Milani A, Muratori F, Rossi B, Waide V,

Logroscino G, Logroscino CA, Maffulli N. Percutaneous acetabuloplasty for

metastatic acetabular lesions. BMC Musculoskelet Disord. 2008 May 5;9:66. doi:

10.1186/1471-2474-9-66. PubMed PMID: 18457594; PubMed Central PMCID: PMC2390555.

254: Hernán MA, Alonso A, Logroscino G. Cigarette smoking and dementia: potential

selection bias in the elderly. Epidemiology. 2008 May;19(3):448-50. doi:

10.1097/EDE.0b013e31816bbe14. Review. PubMed PMID: 18414087.

255: Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G. Parkinson disease

and risk of mortality: a prospective comorbidity-matched cohort study. Neurology.

2008 Apr 15;70(16 Pt 2):1423-30. doi: 10.1212/01.wnl.0000310414.85144.ee. PubMed

PMID: 18413567.

256: Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB.

Adherence to a DASH-style diet and risk of coronary heart disease and stroke in

women. Arch Intern Med. 2008 Apr 14;168(7):713-20. doi:

10.1001/archinte.168.7.713. Erratum in: Arch Intern Med. 2008 Jun

23;168(12):1276. PubMed PMID: 18413553.

257: Kurth T, Logroscino G. The metabolic syndrome: more than the sum of its

components? Stroke. 2008 Apr;39(4):1068-9. doi: 10.1161/STROKEAHA.107.505073.

Epub 2008 Mar 6. PubMed PMID: 18323482.

258: Logroscino G, Hesdorffer DC, Cascino G, Hauser WA. Status epilepticus

without an underlying cause and risk of death: a population-based study. Arch

Neurol. 2008 Feb;65(2):221-4. doi: 10.1001/archneurol.2007.43. PubMed PMID:

18268191.

259: Beghi E, Mennini T, Bendotti C, Bigini P, Logroscino G, Chiò A, Hardiman O,

Mitchell D, Swingler R, Traynor BJ, Al-Chalabi A. The heterogeneity of

amyotrophic lateral sclerosis: a possible explanation of treatment failure. Curr

Med Chem. 2007;14(30):3185-200. Review. PubMed PMID: 18220753.

260: Zoccolella S, Simone IL, Lamberti P, Samarelli V, Tortelli R, Serlenga L,

Logroscino G. Elevated plasma homocysteine levels in patients with amyotrophic

lateral sclerosis. Neurology. 2008 Jan 15;70(3):222-5. doi:

10.1212/01.wnl.0000297193.53986.6f. PubMed PMID: 18195267.

261: Gao X, Chen H, Schwarzschild MA, Logroscino G, Ascherio A. Perceived

imbalance and risk of Parkinson's disease. Mov Disord. 2008 Mar 15;23(4):613-6.

doi: 10.1002/mds.21919. PubMed PMID: 18181208; PubMed Central PMCID: PMC2385782.

262: Logroscino G, Traynor BJ, Hardiman O, Chio' A, Couratier P, Mitchell JD,

Swingler RJ, Beghi E; EURALS. Descriptive epidemiology of amyotrophic lateral

sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008

Jan;79(1):6-11. Review. PubMed PMID: 18079297.

263: Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V,

Lepore V, Simone IL, Lamberti P, Serlenga L, Logroscino G. Predictors of long

survival in amyotrophic lateral sclerosis: a population-based study. J Neurol

Sci. 2008 May 15;268(1-2):28-32. Epub 2007 Nov 19. PubMed PMID: 18021808.

264: Chiò A, Traynor BJ, Swingler R, Mitchell D, Hardiman O, Mora G, Beghi E,

Logroscino G; EURALS consortium. Amyotrophic lateral sclerosis and soccer: a

different epidemiological approach strengthen the previous findings. J Neurol



Sci. 2008 Jun 15;269(1-2):187-8; author reply 188-9. Epub 2007 Nov 8. PubMed

PMID: 17996254.

265: Gao X, Chen H, Fung TT, Logroscino G, Schwarzschild MA, Hu FB, Ascherio A.

Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin

Nutr. 2007 Nov;86(5):1486-94. PubMed PMID: 17991663; PubMed Central PMCID:

PMC2225168.

266: Alonso A, Rodríguez LA, Logroscino G, Hernán MA. Gout and risk of Parkinson

disease: a prospective study. Neurology. 2007 Oct 23;69(17):1696-700. PubMed

PMID: 17954784.

267: Gao X, Chen H, Schwarzschild MA, Glasser DB, Logroscino G, Rimm EB, Ascherio

A. Erectile function and risk of Parkinson's disease. Am J Epidemiol. 2007 Dec

15;166(12):1446-50. Epub 2007 Sep 17. PubMed PMID: 17875583; PubMed Central

PMCID: PMC2385785.

268: Logroscino G, Beghi E, Hardiman O, Chio A, Mitchell JD, Swingler RJ, Traynor

B; EURALS. Effect of referral bias on assessing survival in als. Neurology. 2007

Aug 28;69(9):939; author reply 939-40. PubMed PMID: 17724304.

269: Logroscino G, Sesso HD, Paffenbarger RS Jr, Lee IM. Body mass index and risk

of Parkinson's disease: a prospective cohort study. Am J Epidemiol. 2007 Nov

15;166(10):1186-90. Epub 2007 Aug 20. PubMed PMID: 17709328.

270: Rossetti AO, Logroscino G, Liaudet L, Ruffieux C, Ribordy V, Schaller MD,

Despland PA, Oddo M. Status epilepticus: an independent outcome predictor after

cerebral anoxia. Neurology. 2007 Jul 17;69(3):255-60. PubMed PMID: 17636063.

271: Landi E, Tampieri A, Celotti G, Sprio S, Sandri M, Logroscino G.

Sr-substituted hydroxyapatites for osteoporotic bone replacement. Acta Biomater.

2007 Nov;3(6):961-9. Epub 2007 Jun 19. PubMed PMID: 17618844.

272: Hesdorffer DC, Logroscino G, Cascino GD, Hauser WA. Recurrence of afebrile

status epilepticus in a population-based study in Rochester, Minnesota.

Neurology. 2007 Jul 3;69(1):73-8. PubMed PMID: 17606884.

273: Landi E, Logroscino G, Proietti L, Tampieri A, Sandri M, Sprio S. Biomimetic

Mg-substituted hydroxyapatite: from synthesis to in vivo behaviour. J Mater Sci

Mater Med. 2008 Jan;19(1):239-47. Epub 2007 Jun 28. PubMed PMID: 17597369.

274: Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G. Prospective

case-control study of nonfatal cancer preceding the diagnosis of Parkinson's

disease. Cancer Causes Control. 2007 Sep;18(7):705-11. Epub 2007 Jun 12. PubMed

PMID: 17562193.


Lepore V, Simone IL, Lamberti P, Serlenga L, Logroscino G; SLAP Registry.

Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a

population based study. J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):33-7. Epub

2007 Jun 5. PubMed PMID: 17550991.

276: Driver JA, Logroscino G, Buring JE, Gaziano JM, Kurth T. A prospective

cohort study of cancer incidence following the diagnosis of Parkinson's disease.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1260-5. PubMed PMID: 17548694.

277: Logroscino G, Zoccolella S. Efficacy of riluzole: who are the patients

enrolled in the studies? Amyotroph Lateral Scler. 2007 Apr;8(2):124-5; author

reply 125. PubMed PMID: 17453643.

278: Kurth T, Gaziano JM, Cook NR, Bubes V, Logroscino G, Diener HC, Buring JE.



Migraine and risk of cardiovascular disease in men. Arch Intern Med. 2007 Apr

23;167(8):795-801. PubMed PMID: 17452542.

279: Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Lepore V, Simone

IL, Lamberti P, Serlenga L, Logroscino G. ALS multidisciplinary clinic and

survival. Results from a population-based study in Southern Italy. J Neurol. 2007

Aug;254(8):1107-12. Epub 2007 Apr 13. PubMed PMID: 17431705.

280: Sanz P, Nogué S, Vilchez D, Vilchez J, Casal A, Logroscino G. Progressive

supranuclear palsy-like parkinsonism resulting from occupational exposure to lead

sulphate batteries. J Int Med Res. 2007 Jan-Feb;35(1):159-63. PubMed PMID:

17408069.

281: Janghorbani M, Hu FB, Willett WC, Li TY, Manson JE, Logroscino G, Rexrode

KM. Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes:

the Nurses' Health Study. Diabetes Care. 2007 Jul;30(7):1730-5. Epub 2007 Mar 27.


282: Logroscino G, Armon C. Amyotrophic lateral sclerosis: a global threat with a

possible difference in risk across ethnicities. Neurology. 2007 Mar

27;68(13):E17. PubMed PMID: 17389297.


Lepore V, Simone IL, Lamberti P, Serlenga L, Logroscino G; SLAP registry.

Riluzole and amyotrophic lateral sclerosis survival: a population-based study in

southern Italy. Eur J Neurol. 2007 Mar;14(3):262-8. PubMed PMID: 17355545.

284: Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G; SLALOM Group.

Incidence of ALS in Lombardy, Italy. Neurology. 2007 Jan 9;68(2):141-5. PubMed

PMID: 17210896.

285: Misciagna G, Logroscino G, De Michele G, Guerra V, Cisternino AM, Caruso MG,

Trevisan M. Glycated apolipoprotein B and myocardial infarction. Nutr Metab

Cardiovasc Dis. 2007 Jan;17(1):6-12. PubMed PMID: 17169539.

286: Beghi E, Logroscino G, Chiò A, Hardiman O, Mitchell D, Swingler R, Traynor

BJ; EURALS Consortium. The epidemiology of ALS and the role of population-based

registries. Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):1150-7. Epub 2006 Sep


287: Logroscino G, Sesso HD, Paffenbarger RS Jr, Lee IM. Physical activity and

risk of Parkinson's disease: a prospective cohort study. J Neurol Neurosurg

Psychiatry. 2006 Dec;77(12):1318-22. Epub 2006 Aug 22. PubMed PMID: 16926235;


288: Zoccolella S, Beghi E, Palagano G, Fraddosio A, Samarelli V, Lamberti P,

Lepore V, Serlenga L, Logroscino G; SLAP registry. Predictors of delay in the

diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a

population-based study. J Neurol Sci. 2006 Dec 1;250(1-2):45-9. Epub 2006 Aug 22.


289: Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Unreported

financial disclosures in a study of migraine and cardiovascular disease. JAMA.

2006 Aug 9;296(6):653-4; author reply 654. PubMed PMID: 16896106.

290: Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine

and risk of cardiovascular disease in women. JAMA. 2006 Jul 19;296(3):283-91.

Erratum in: JAMA. 2006 Aug 9;296(6):654. JAMA. 2006 Jul 19;296(3):1 p following

291. PubMed PMID: 16849661.



291: Zoccolella S, Beghi E, Palagano G, Fraddosio A, Samarelli V, Lamberti P,

Lepore V, Serlenga L, Logroscino G; SLAP registry. Signs and symptoms at

diagnosis of amyotrophic lateral sclerosis: a population-based study in southern

Italy. Eur J Neurol. 2006 Jul;13(7):789-92. PubMed PMID: 16834713.

292: Rossetti AO, Logroscino G, Bromfield EB. A clinical score for prognosis of

status epilepticus in adults. Neurology. 2006 Jun 13;66(11):1736-8. PubMed PMID:

16769951.

293: Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB. Prognosis of status

epilepticus: role of aetiology, age, and consciousness impairment at

presentation. J Neurol Neurosurg Psychiatry. 2006 May;77(5):611-5. PubMed PMID:


294: Hernán MA, Logroscino G, García Rodríguez LA. Nonsteroidal anti-inflammatory

drugs and the incidence of Parkinson disease. Neurology. 2006 Apr

11;66(7):1097-9. PubMed PMID: 16606925.

295: Bowirrat A, Oscar-Berman M, Logroscino G. Association of depression with

Alzheimer's disease and vascular dementia in an elderly Arab population of

Wadi-Ara, Israel. Int J Geriatr Psychiatry. 2006 Mar;21(3):246-51. PubMed PMID:

16477584.

296: Logroscino G, Chen H, Wing A, Ascherio A. Blood donations, iron stores, and

risk of Parkinson's disease. Mov Disord. 2006 Jun;21(6):835-8. PubMed PMID:

16453313.

297: Kurth T, Logroscino G. Can we escape stroke and Alzheimer disease? Stroke.

2006 Feb;37(2):279-80. Epub 2006 Jan 5. PubMed PMID: 16397177.

298: Logroscino G, Hesdorffer DC, Cascino G, Hauser WA, Coeytaux A, Galobardes B,

Morabia A, Jallon P. Mortality after a first episode of status epilepticus in the

United States and Europe. Epilepsia. 2005;46 Suppl 11:46-8. Review. PubMed PMID:

16393180.

299: Diop AG, Hesdorffer DC, Logroscino G, Hauser WA. Epilepsy and mortality in

Africa: a review of the literature. Epilepsia. 2005;46 Suppl 11:33-5. Review.


300: Logroscino G, Hesdorffer DC. Methodologic issues in studies of mortality

following epilepsy: measures, types of studies, sources of cases, cohort effects,

and competing risks. Epilepsia. 2005;46 Suppl 11:3-7. Review. PubMed PMID:

16393170.

301: Zoccolella S, Beghi E, Serlenga L, Logroscino G. Classification of

amyotrophic lateral sclerosis cases at presentation in epidemiological studies.

Neurol Sci. 2005 Dec;26(5):330-3. PubMed PMID: 16388367.

302: Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus:

effect of treatment aggressiveness on prognosis. Arch Neurol. 2005

Nov;62(11):1698-702. Erratum in: Arch Neurol. 2006 Oct;63(10):1482. PubMed PMID:

16286542.

303: Logroscino G. The role of early life environmental risk factors in Parkinson

disease: what is the evidence? Environ Health Perspect. 2005 Sep;113(9):1234-8.


304: Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL,

Lamberti P, Lepore V, Serlenga L; SLAP Registry. Incidence of amyotrophic lateral

sclerosis in southern Italy: a population based study. J Neurol Neurosurg



Psychiatry. 2005 Aug;76(8):1094-8. PubMed PMID: 16024886; PubMed Central PMCID:

PMC1739746.

305: Millul A, Beghi E, Logroscino G, Micheli A, Vitelli E, Zardi A. Survival of

patients with amyotrophic lateral sclerosis in a population-based registry.

Neuroepidemiology. 2005;25(3):114-9. Epub 2005 Jun 13. PubMed PMID: 15956808.

306: Hernán MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, Jick H. Cigarette

smoking and the progression of multiple sclerosis. Brain. 2005 Jun;128(Pt

6):1461-5. Epub 2005 Mar 9. PubMed PMID: 15758034.

307: Misciagna G, De Michele G, Cisternino AM, Guerra V, Logroscino G,

Freudenheim JL. Dietary carbohydrates and glycated proteins in the blood in non

diabetic subjects. J Am Coll Nutr. 2005 Feb;24(1):22-9. PubMed PMID: 15670981.

308: Kang JH, Logroscino G, De Vivo I, Hunter D, Grodstein F. Apolipoprotein E,

cardiovascular disease and cognitive function in aging women. Neurobiol Aging.

2005 Apr;26(4):475-84. PubMed PMID: 15653176.

309: Logroscino G, Lipton RB. Migraine is associated with chest symptoms but not

cardiac events: a reassuring paradox. Neurology. 2004 Dec 28;63(12):2209-10.


310: Hernán MA, Logroscino G, Rodríguez LA. A prospective study of alcoholism and

the risk of Parkinson's disease. J Neurol. 2004 Oct;251 Suppl 7:vII14-7. PubMed

PMID: 15505749.

311: Gallitelli M, Lepore V, Pasculli G, Di Gennaro L, Logroscino G, Carella A,

White RI, Sabbà C. Brain abscess: a need to screen for pulmonary arteriovenous

malformations. Neuroepidemiology. 2005;24(1-2):76-8. Epub 2004 Sep 24. PubMed

PMID: 15459513.

312: Beghi E, Gandolfo C, Ferrarese C, Rizzuto N, Poli G, Tonini MC, Vita G,

Leone M, Logroscino G, Granieri E, Salemi G, Savettieri G, Frattola L, Ru G,

Mancardi GL, Messina C. Bovine spongiform encephalopathy and Creutzfeldt-Jakob

disease: facts and uncertainties underlying the causal link between animal and

human diseases. Neurol Sci. 2004 Jul;25(3):122-9. Review. PubMed PMID: 15300459.

313: Chen H, Zhang SM, Schwarzschild MA, Hernán MA, Logroscino G, Willett WC,

Ascherio A. Folate intake and risk of Parkinson's disease. Am J Epidemiol. 2004

Aug 15;160(4):368-75. PubMed PMID: 15286022.

314: Logroscino G, Kang JH, Grodstein F. Prospective study of type 2 diabetes and

cognitive decline in women aged 70-81 years. BMJ. 2004 Mar 6;328(7439):548. Epub

2004 Feb 23. PubMed PMID: 14980984; PubMed Central PMCID: PMC381043.

315: Misciagna G, Logroscino G, De Michele G, Cisternino AM, Guerra V,

Freudenheim JL. Fructosamine, glycated hemoglobin, and dietary carbohydrates.

Clin Chim Acta. 2004 Feb;340(1-2):139-47. PubMed PMID: 14734205.

316: Savettieri G, Andreoli V, Bonavita S, Cittadella R, Caltagirone C, Fazio MC,

Girlanda P, Le Pira F, Liguori M, Logroscino G, Lugaresi A, Nocentini U, Reggio

A, Salemi G, Serra P, Tedeschi G, Toma L, Trojano M, Valentino P, Quattrone A.

Apolipoprotein E genotype does not influence the progression of multiple

sclerosis. J Neurol. 2003 Sep;250(9):1094-8. PubMed PMID: 14504972.

317: Defazio G, Martino D, Aniello MS, Masi G, Logroscino G, Manobianca G, La

Stilla M, Livrea P. Influence of age on the association between primary

hemifacial spasm and arterial hypertension. J Neurol Neurosurg Psychiatry. 2003

Jul;74(7):979-81. PubMed PMID: 12810800; PubMed Central PMCID: PMC1738545.



318: Mastrolonardo M, Diaferio A, Logroscino G. Seborrheic dermatitis, increased

sebum excretion, and Parkinson's disease: a survey of (im)possible links. Med

Hypotheses. 2003 Jun;60(6):907-11. PubMed PMID: 12699724.

319: Pola E, Logroscino G, De Santis V, Canducci F, Delcogliano A, Gasbarrini A.

Onset of Berger disease after Staphylococcus aureus infection: septic arthritis

after anterior cruciate ligament reconstruction. Arthroscopy. 2003 Apr;19(4):E29.


320: Logroscino G, Livrea P, Anaclerio D, Aniello MS, Benedetto G, Cazzato G,

Giampietro L, Manobianca G, Marra M, Martino D, Pannarale P, Pulimeno R,

Santamato V, Defazio G. Agreement among neurologists on the clinical diagnosis of

dystonia at different body sites. J Neurol Neurosurg Psychiatry. 2003

Mar;74(3):348-50. PubMed PMID: 12588923; PubMed Central PMCID: PMC1738354.

321: Beghi E, Balzarini C, Bogliun G, Logroscino G, Manfredi L, Mazzini L,

Micheli A, Millul A, Poloni M, Riva R, Salmoiraghi F, Tonini C, Vitelli E;

Italian ALS Study Group. Reliability of the El Escorial diagnostic criteria for

amyotrophic lateral sclerosis. Neuroepidemiology. 2002 Nov-Dec;21(6):265-70.


322: Marder K, Logroscino G. The ever-stimulating association of smoking and

coffee and Parkinson's disease. Ann Neurol. 2002 Sep;52(3):261-2. PubMed PMID:

12205636.

323: Mazza O, Logroscino G, Pola E, Aulisa AG, Mastantuoni G, Aulisa L. [Pott

disease: current diagnostic and therapeutic approaches]. Clin Ter. 2001

Nov-Dec;152(6):369-76. Review. Italian. PubMed PMID: 11865533.

324: Logroscino G, Hesdorffer DC, Cascino GD, Annegers JF, Bagiella E, Hauser WA.

Long-term mortality after a first episode of status epilepticus. Neurology. 2002

Feb 26;58(4):537-41. PubMed PMID: 11865129.

325: Logroscino G, Mazza O, Aulisa G, Pitta L, Pola E, Aulisa L. Spondylolysis

and spondylolisthesis in the pediatric and adolescent population. Childs Nerv

Syst. 2001 Nov;17(11):644-55. Epub 2001 Oct 27. Review. PubMed PMID: 11734982.

326: Beghi E, Logroscino G, Micheli A, Millul A, Perini M, Riva R, Salmoiraghi F,

Vitelli E; Italian ALS Registry Study Group. Validity of hospital discharge

diagnoses for the assessment of the prevalence and incidence of amyotrophic

lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001

Jun;2(2):99-104. PubMed PMID: 11675878.

327: Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA. Time trends

in incidence, mortality, and case-fatality after first episode of status

epilepticus. Epilepsia. 2001 Aug;42(8):1031-5. PubMed PMID: 11554890.

328: Oliveri RL, Zappia M, Annesi G, Annesi F, Spadafora P, Pasqua AA, Tomaino C,

Nicoletti G, Bosco D, Messina D, Logroscino G, Manobianca G, Epifanio A, Morgante

L, Savettieri G, Quattrone A. The parkin gene is not a major susceptibility locus

for typical late-onset Parkinson's disease. Neurol Sci. 2001 Feb;22(1):73-4.


329: Oliveri RL, Zappia M, Annesi G, Bosco D, Annesi F, Spadafora P, Pasqua AA,

Tomaino C, Nicoletti G, Pirritano D, Labate A, Gambardella A, Logroscino G,

Manobianca G, Epifanio A, Morgante L, Savettieri G, Quattrone A. The parkin gene

is not involved in late-onset Parkinson's disease. Neurology. 2001 Jul

24;57(2):359-62. PubMed PMID: 11468333.



330: Defazio G, Livrea P, De Salvia R, Manobianca G, Coviello V, Anaclerio D,

Guerra V, Martino D, Valluzzi F, Liguori R, Logroscino G. Prevalence of primary

blepharospasm in a community of Puglia region, Southern Italy. Neurology. 2001

Jun 12;56(11):1579-81. PubMed PMID: 11402121.

331: Specchia N, Pagnotta A, Gigante A, Logroscino G, Toesca A. Characterization

of cultured human ligamentum flavum cells in lumbar spine stenosis. J Orthop Res.

2001 Mar;19(2):294-300. PubMed PMID: 11347704.

332: Cascino GD, Hesdorffer D, Logroscino G, Hauser WA. Treatment of nonfebrile

status epilepticus in Rochester, Minn, from 1965 through 1984. Mayo Clin Proc.

2001 Jan;76(1):39-41. PubMed PMID: 11155411.

333: Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Risk of

unprovoked seizure after acute symptomatic seizure: effect of status epilepticus.

Ann Neurol. 1998 Dec;44(6):908-12. PubMed PMID: 9851435.

334: Cascino GD, Hesdorffer D, Logroscino G, Hauser WA. Morbidity of nonfebrile

status epilepticus in Rochester, Minnesota, 1965-1984. Epilepsia. 1998

Aug;39(8):829-32. PubMed PMID: 9701372.

335: Logroscino G, Marder K, Graziano J, Freyer G, Slavkovich V, Lojacono N, Cote

L, Mayeux R. Dietary iron, animal fats, and risk of Parkinson's disease. Mov

Disord. 1998;13 Suppl 1:13-6. PubMed PMID: 9613713.

336: Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA. Short-term

mortality after a first episode of status epilepticus. Epilepsia. 1997

Dec;38(12):1344-9. PubMed PMID: 9578531.

337: Marder K, Logroscino G, Tang MX, Graziano J, Cote L, Louis E, Alfaro B,

Mejia H, Slavkovich V, Mayeux R. Systemic iron metabolism and mortality from

Parkinson's disease. Neurology. 1998 Apr;50(4):1138-40. PubMed PMID: 9566409.

338: Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Incidence of

status epilepticus in Rochester, Minnesota, 1965-1984. Neurology. 1998

Mar;50(3):735-41. PubMed PMID: 9521266.

339: Marder K, Logroscino G, Alfaro B, Mejia H, Halim A, Louis E, Cote L, Mayeux

R. Environmental risk factors for Parkinson's disease in an urban multiethnic

community. Neurology. 1998 Jan;50(1):279-81. PubMed PMID: 9443493.

340: Logroscino G, Marder K, Graziano J, Freyer G, Slavkovich V, LoIacono N, Cote

L, Mayeux R. Altered systemic iron metabolism in Parkinson's disease. Neurology.

1997 Sep;49(3):714-7. PubMed PMID: 9305329.

341: Logroscino G, Mayeux R. Diet and Parkinson's disease. Neurology. 1997

Jul;49(1):310-1. PubMed PMID: 9222221.

342: Schofield PW, Logroscino G, Andrews HF, Albert S, Stern Y. An association

between head circumference and Alzheimer's disease in a population-based study of

aging and dementia. Neurology. 1997 Jul;49(1):30-7. PubMed PMID: 9222166.

343: Logroscino G, Marder K, Cote L, Tang MX, Shea S, Mayeux R. Dietary lipids

and antioxidants in Parkinson's disease: a population-based, case-control study.

Ann Neurol. 1996 Jan;39(1):89-94. PubMed PMID: 8572672.

344: Solari A, Amato MP, Bergamaschi R, Logroscino G, Citterio A, Bochicchio D,

Filippini G. Accuracy of self-assessment of the minimal record of disability in

patients with multiple sclerosis. Acta Neurol Scand. 1993 Jan;87(1):43-6. PubMed

PMID: 8424310.

345: Trojano M, Logroscino GC, Pisicchio L, Rosato A, Bordo B, Citterio A, Amato



MP, Livrea P. The Multiple Sclerosis Cooperative Etiological Study in Italy:

preliminary analysis of CSF findings. Ital J Neurol Sci. 1987 Jun;Suppl 6:71-6.


346: Livrea P, Simone IL, Trojano M, Pisicchio L, Logroscino G, Rosato A.

Cerebrospinal fluid (CSF) parameters and clinical course of multiple sclerosis.

Riv Neurol. 1987 May-Jun;57(3):189-96. PubMed PMID: 3672011.

347: Trojano M, Simone IL, Logroscino G, Pisicchio L, Rosato A, Ragno T, Gaudiuso

MR, Livrea P. Blood-cerebrospinal fluid barrier permeability to serum IgG

subfractions and measurement of intrathecal IgG synthesis. J Neurol Sci. 1986

May;73(3):325-38. PubMed PMID: 3014065.

348: Livrea P, Trojano M, Simone IL, Zimatore GB, Logroscino GC, Pisicchio L,

Lojacono G, Colella R, Ceci A. Acute changes in blood-CSF barrier permselectivity

to serum proteins after intrathecal methotrexate and CNS irradiation. J Neurol.

1985;231(6):336-9. PubMed PMID: 3855968.

349: Livrea P, Trojano M, Simone IL, Zimatore GB, Pisicchio L, Logroscino G,

Cibelli G. Heterogeneous models for blood-cerebrospinal fluid barrier

permeability to serum proteins in normal and abnormal cerebrospinal fluid/serum

protein concentration gradients. J Neurol Sci. 1984 Jun;64(3):245-58. PubMed

PMID: 6206205.

350: Fumarola D, Miragliotta C, Logroscino G, Castellani Pastoris M. Simultaneous

infection with Legionella pneumophila and Legionella micdadei in an

immunologically intact host. A case report. Boll Ist Sieroter Milan. 1984 May

31;63(2):165-6. PubMed PMID: 6466457.

351: Dina MA, Logroscino GS, Caprino L, Togna G. [Ultrastructural study of the

activity of phospholipids in experimental liver damage induced by isoniazide].

Farmaco Sci. 1975 Dec;30(12):955-64. Italian. PubMed PMID: 1204833.

EDITOR DI TEXTBOOK INTERNAZIONALI:

- “The Right Therapy for Neurological Disorders.From Randomized Trials to Clinical Practice”

Editors: Giancarlo Logroscino - Ettore Beghi

Karger, 2016.

- Oxford Textbook of Neurological and Neuropsychiatric Epidemiology.

Oxford University Press

(Editors by: Carol Brayne, Valery Feigin, Lenore Launer and Giancarlo Logroscino).

Work in progress

CAPITOLI DI TEXTBOOK INTERNAZIONALI:

- Handbook of Clinical Neurology, Vol. 84 (3rd series)

Titolo del contributo: Epidemiology of alphasynucleinopathies from Parkinson’ disease to Dementia with Lewy Bodies

(Savica R., Boeve B. Logroscino G.)

Parkinson’s disease and related disorders, Part II

W. C. Koller, E. Melamed, Editors, 2016

- Imaging in Neurodegenerative Disorders.

Titolo del contributo: “Epidemiology of Neurodegenerative Diseases” (Logroscino G., Tortelli R.)

Edited by Luca Saba;

Oxford University Press, 2015

- Motor Neuron Disease in Adults

Titolo del contributo : “Epidemiology of Amyotrophic Lateral Sclerosis” (Logroscino G., Chiò A.)



Edited by Mark Bromberg

Oxford University Press, 2014

- The IUPHAR Compendium of Basic Principles For Pharmacological Research in Humans

Titolo del contributo: Alzheimer’s Disease and Other Dementias

Editors: Patrick du Souich, Michael Orme and Sergio Erill.

IUPHAR, 2004.

Projects • SLAPDem: Registro di Popolazione Pugliese affetto da SLA-FTD-DLB. funded by Regione Puglia Delibera 1284/2015 (Principal Investigator)

• Title Project "Punto Malattie Neurodegenerative in Albania" funded by Regione Puglia Program "Legge 20" (Principal Investigator)

• Project funded by Regione Puglia: “GreatAge Aging in populations” Population study in Castellana Grotte (BA) .(Principal Investigator)

• Euro-MOTOR FP7/2007-2013 - European multidisciplinary ALS network identification to cure motoneuron degeneration” - Grant agreement 259867 Scientific Coordinator for Regione Puglia.

• “LAENALS, Latin American Epidemiologic Network for ALS” - Analyze and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)”- GRANT11874140; fundend by Center for Disease Control di Atlanta, Georgia,

• PRIN 2009: "Impact of the central and peripheral hearing loss on the risk of onset of subjective cognitive impairment, mild cognitive impairment, dementia, Alzheimer's disease, vascular dementia and depression late onset. (Principal Investigator)

• Project “Malattia Alzheimer: Anticipiamo la diagnosi” 2011- Novartis - Observational study.

• Project “CCM 2009: Organization of a care pathway designed to prevent complications and improve the quality of life for patients with amyotrophic lateral sclerosis. Project funded by Ministero della Salute (DM 8 luglio 2009)”. Referent of Unit ALS, Policlinico di Bari, University of Bari;

• Genetic and epidemiological study of sporadic and familial forms of FTD in the Puglia region.

Aut. CE prot 3789 del 27/07/2011;

• “Safety and Efficacy of Erythropoietin in Amyotrophic Lateral Sclerosis: A Randomized, Placebo-Controlled Clinical Trial” Codice: Epo200901 Eudra Ct Number:2009-016066-91 (Ministero della Salute);

• EURALS European Registry of Amyotrophic lateral sclerosis;

• Project "Study of the possible association between seasonal flu vaccination and the onset of Guillain-Barré syndrome " (Ministero della Salute)

• Project “Genetic and environmental predictors of early onset of Amyotrophic Lateral Sclerosis

(Principal Investigator);

• Project Qualifycare for ALS Guideelines in the Puglia Region;

• Ricerca e Competitività 2007-2013: Smarth Health 2.0 PON4a2 Project;

• Project "Regional Registry for ALS, the TFD-P and related conditions in Puglia."Project funded by Regione Puglia (D.G.R. n. 1284/2015). Scientific Coordinator

• New diagnostic and prognostic genetic biomarkers in lewy bodies disease (LBD)

Principal Investigator: Giancarlo Logroscino

• New diagnostic and prognostic plasma biomarkers in frontotemporal dementia (ftd) and lewy bodies disease (lbd)

Principal Investigator: Giancarlo Logroscino . Co.Pi: Michelle Mielke - Department of health, sciences, research - Mayo Clinic, Rochester (MN), USA. Approvato dal Comitato Etico di Lecce in data 07.07.2016 con verbale n. 38;

• “Evolution: behavioral symptoms in Alzheimer’s disease: evaluation of patients treated with cholinesterase inhibitors”

• “Screening per demenza e parkinsonismo nella popolazione generale”

• Epidemiological and genetic study of sporadic and familial forms of fronto-temporal dementia in Puglia Principal Investigator: Giancarlo Logroscino. Co.Pi: Andrew Singleton - Chief, Laboratory of Neurogenetics, national Institute on aging, national institutes of health, bethesda, MD, USA



Reseach Consulting Activity

1995-97

Special Project Associate Scientist

Health Science Research.

Mayo Clinic and Mayo Foundation Rochester (MN)

Clinical Research Trials:

2016 Phase 2b, randomized, double-blind, placebo-controlled RVT-101-2001 in patients with dementia with Lewy bodies (DLB) Approved by the Ethical Commitee ASL Lecce on 28.07.2016 (Principal Investigator);

2016 221AD302 - Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and rrrrrrrrrrrrrSafety of Aducanumab (BIIB037) in Subjects with Early Alzheimer's Disease. Approved by the Ethical Commitee ASL on

13.01.2016 (Principal Investigator);

2015 Proposal to build a register of healthy volunteers with normal cognitive function in the Puglia Region.

Sponsor: Takeda. Codice Protocollo AD4833 TOMM40_301 Approved by the Ethical Commitee ASL Lecce on 05.03.2015

(Principal Investigator);

2012 Late onset Parkinson's disease in subjects 70 year and older: possible use of rotigotine. "PARROT".

Memberships International Boards

2017 National Agency of French Research as a member of the jury for the evaluation of projects "cohorts" flipping in 2010

2016 Member of American Brain Foundation (ABF);

2015 International Member of the Evaluation Committee (AERES) of the "Bordeaux Research Center for Population Health” – Bordeaux – France;

2014 Convenor World Congress of Neurology organized by WFN: Wien 2014 – Santiago (Chile) 2015;

2011 Member of the Task Force Neurologica of Global Burden of Disease;

2011-2013 Member of the task force dell’American Academy of Neurology for

“Evidence Based Medicine” (EBM) in Neurology;

2010- Commission on Epidemiology and Classification of ILA

International League against Epilepsy: Chairman Special group on Mortality;

2010 Member of the internation jury for Department Investissement D’Avenir” – Cohorts Evaluation Committee” nominated by French gouvernement;

2010 Task force for European clinical trials of new drugs in ALS

European ALS Consortium. ENCALS;

2007- 8 ALS expert Panel for the State of Massachusetts;

2006-8 WFN (World Federation of Neurology) Committee for New Guidelines for ALS;

2004- Member of the“Neuroepidemiology Research Group” di Harvard University (USA);

2002- EURALS European project for the Epidemiological Studies of ALS;

2004-8 American Study group for Environment and Epidemiology of Parkinson’s Disease;

Italian Boards

2016 Member of the Parkinson Commitee of Regione Puglia;

2016 Scientific Coordinator for the scientific convention between University of Bari and:

- University of Medicine di Tirana (Albania). Delibera S.A. del 11.04.2016/p.13;

- University of Limoges (Francia); Delibera S.A. del 02.02.2016/p.5;

- European Brain Research Institute (EBRI-Roma)/Pia Fondazione “Card, G. Panico”-Tricase (Le). Delibera S.A. del 09.11.2016;



2015 Member of the commitee of “Ministero della Sanità” for the study Session

Evaluation of projects Health Biomedical Research

from 2014-2018 President NEP (Italian Neuroepidemiology Association);

from 2014 Member of Commitee Board S.I.N. (Italian Neurology Society);

from 2013 Member of the Scientific Commitee of Sindem (Dementia Association);

2011- 2013 Scientific Commitee of ARISLA;

2010-2012 Member of the Ethic Commitee of Hospital “Policlinico of Bari”;

2009 Member of “Neuromuscolar Diseases Board”, Ministero del Lavoro, della Salute e delle PoliticheSociali (D.M. Lavoro, Salute e Politiche Sociali del 27 febbraio 2009);

from 2009 Member of the “Rare Diseases Regional Board” (COReMAR) – Puglia, DGR 2485/2009;

2006-8 National Scientific Commitee AISLA

Professional Society

2016 Member of International Society for Frontotemporal Dementia (ISFTD);

2007- American Neurological Association (ANA);

-1991 American Academy of Neurology, Clinical Associate, FAAN;

-1984 Italian Society of Neuroepidemiology (NEP).

Cursus Honorum

2014-2016

2014-2016 Chair of the Neuroepidemiology section American Academy of Neurology

Member of the Committee of the Chairs of Sections (COS) of the American Academy of Neurology

2017- Member of Applied Research Committee (ARC) of Word Federation of Neurology

2011-13 Elected chair Section of Neuroepidemiology American Academy of Neurology

2007- Chair of the Neuroepidemiology Group of the Word Federation of Neurology

2005- Fellow of the American Academy of Neurology (FAAN) - American Academy of Neurology

1997

PhD degree with distinctions Graduate School of Arts and Sciences

Columbia University, New York, NY USA

2014-2016

2014-2016 Chair of the Neuroepidemiology section American Academy of Neurology

Member of the Committee of the Chairs of Sections (COS) of the American Academy of Neurology

Other Relevant Information Teaching Activity

2008-

Neurology.

Faculty of Medicine. University of Bari “Aldo Moro”

2002-07 Associate Professor

“Epidemiology of Neurological Diseases” Course

Diploma Master Degree a Doctoral Degree

School of Public Health e School of Medicine - Harvard University

2002-07 “Clinical Epidemiology” Course

School of Medicine and School of Public Health -

Harvard University

2002-07 “Mentor’ activity for student of the Master Degree and Doctoral degree

School of Public Health e School of Medicine- Harvard University

2002-07 Special Advisoring e Teaching per Minority students e International students.

School of Public Health e School of Medicine. Harvard University.

2001 Epidemiologic methods in the study of the diseases of aging with W.A.



Hauser Columbia University. New York NY

Mediterranean School of Epidemiology and Statistical Methods in Biomedical Research

Isola di Capo Rizzuto, 3-9-2001/29-9-2001

Consiglio Nazionale delle Ricerche

2000 Evidence-Based-Medicine in Neurology:

Methods in analytic research

EBM Teaching Group

Italian Society of Neuroepidemiology

1992-97 Faculty Research Scientist

Gertrude Sergievsky Center


1996 Lecturer

Epidemiology IV (Epidemiological Theory and Methods)

Pam Factor-Litvak PhD. Department of Epidemiology


1995-97 Teaching Assistant.

Epidemiology I (Fundamentals of Epidemiology).

Richard Neugebauer PhD. Department of Epidemiology


Special Teaching activity in International or National courses

2018 I LATIN AMERICAN COURS OF NEUROEPIDEMIOLOGY

Theacer

2017 Faculty in the “International Course of Neuroepidemiology, Clinical Neurology and Research Methods

in low income Countries “ - (Cambogia, Laos). Whit the endorsement of WFN.

2017 II° Course “Inter-company training on cerebrovascular diseases”

Messina – Sicilia - Italy

Title: L’epidemiologia dell’Ictus

2016 Istituto di Neuroepidemiologia

Montevideo – Uruguay

Faculty in the “Experimental vs. Non-experimental Methods” course

2016 Scientific coordinator for ’University of Bari in the project : “National network of young researchers engaged in research on Alzheimer's disease ". Research project with the fundo of Coop-AIRAlzh (Associazione italiana ricerca Alzheimer) e University of Firenze.

2016 "Teaching Activity Elective”

Postural Instability in Elderly: Understanding Risk Factors&Best Practices

May 2016 – School of Medicine – University of Bari

2015-16 Member of the jury of the master «Neuroépidémiologie et Parasitologie Tropicales» University of Limoges, France e responsabile dell’unità « Methods in Neuroepidemiology » Tricase, Italy;

2015 International Conference on Neurology&Epidemiology (ICNE)

Gold Coast - Australia

18 Novembre:

Teaching Session: Methods in Neuroloepidemilogy – Clinical Trials

Teaching Session: Methods in Neuroloepidemilogy – Efficacy vs effectiveness

20 Novembre

Teaching Session: Methods in Neuroloepidemilogy - Setting of epidemiological studies

2015 Teaching for the project “Magna Grecia” (Progetto n. 00298/F1) - PON “R&C 2007-2013”



Decreto Direttoriale prot. 254/Ric. Del 18 maggio 2011;

2015 III° Course "The Biomarkers in Alzheimer's Disease and Dementia Diagnosis"

Genova – Scuola Superiore di Neurologia – Prof. Giancarlo Comi

Title: Application to the diagnosis of Alzheimer's Disease;

2013 “Feeding in physiological and pathological conditions"” Course

Teaching on “Prevention of neurological diseases through diet”

Cittadella della Carità - Taranto – Marzo 2013;

2011 “Interventions for the training of Italian residents in non-EU countries”. Avviso 1/07 del 30 luglio 2007. Project: "Social work in clinical psychiatry".Caracas – Venezuela – Course supported by Ministero degli Esteri;

Dal 2004-al 2017 Teaching at Ettore Maiorana International School di Erice (TR) for the International course “Neuroepidemiology methods and clinical applications”. Six sessions

Awards

At 2017

Top Italian Scientist - Category: “Clinical sciences” rank 37 -

2009 "Il campione per la scienza" Award VIII edition, 2009, Milan

1984 “Giuseppe Tinelli” Award – 1983-84.

Facolty of Medicine. University of Bari “Aldo Moro”

1981 “Serafino d’Antona” Award 1979-80.

Facolty of Medicine. University of Bari “Aldo Moro”

Partecipation at congress as speakers from 1995

International Event: 48

National Event: 88

A- - Associate Editor Neuroepidemiology from 1.1.2008

- Member of Editorial Board for Journal of Alzheimer Disease from January 2017

- Nutritional Review – Neurological Diseases

B- Reviewers for the following journals indexed to PUBMED:

1. Acta Neurologica Scandinavica

2. American Journal of Epidemiology

3. Annals of Neurology

4. Archives of Neurology

5. BMC Neurology

6. British Journal of Nutrition

7. BMJ - British Medical Journal

8. Canadian Medical Journal

9. Canadian Neurological Journal

10. Clinical Chemistry

11. Diabetes Care

12. Environmental Health Perspective

13. Epidemiology

14. Epilepsia

15. European Journal of Epidemiology

16. European Journal of Neurology

17. JAMA

18. Journal of Alzheimer’s Disease

19. Journal of Clinical Psychopharmacology

20. Journal of Neurological Diseases and Treatment

21. Journal of Neurology Neurosurgery and Psychiatry



22. Lancet Neurology

23. Metabolism

24. Movement Disorders

25. Nature communications

26. Neuroepidemiology

27. Neurological Sciences

28. Neurology

29. Neurotoxicology

30. Neurotoxicology and Teratology

31. New England Journal of Medicine

32. Nutritional Public Health Journal

33. Plos One

34. Stroke

35. Trials

C- Reviewers for grants to the following organizations:

1. French Government: Cohort action

2. UK diabetes Association

3. Royal Societies of New Zeeland

4. Italian Amyotrophic Lateral Sclerosis Association

5. US Army Medical Association (ABI)

6. UK Parkinson’ Disease Association

7. Agencie National Research French Goverment. Special Call “Cohort”

8. Tollkit Evidence-Based-Medicine in Neurology (EBM)


personal information giancarlo logroscino …€¦ · personal information giancarlo logroscino ......

Documents